<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Urinary incontinence after prostate treatment</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Urinary incontinence after prostate treatment</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Urinary incontinence after prostate treatment</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Craig V Comiter, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jacqueline Speed, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jerome P Richie, MD, FACS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 01, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H158970329"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Urinary incontinence is a known complication of prostate treatment that can significantly adversely impact quality of life [<a href="#rid1">1</a>]. Though it predominantly affects men after radical prostatectomy (RP) for prostate cancer, procedures for benign prostatic conditions can also result in urinary leakage. </p><p>Incontinence after prostate treatment (IPT) is a dynamic condition and can greatly improve in the first one to two years with conservative therapies. Ultimately, 5 percent of men choose to undergo an additional procedure for the treatment of their incontinence [<a href="#rid2">2</a>]. </p><p>The classification, pathophysiology, risk factors, and management of IPT are discussed below. Incontinence in men not related to prostate surgery and specifics regarding the management of prostate cancer and benign prostatic hyperplasia are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/14611.html" rel="external">"Urinary incontinence in men"</a> and  <a class="medical medical_review" href="/z/d/html/6944.html" rel="external">"Radical prostatectomy for localized prostate cancer"</a> and  <a class="medical medical_review" href="/z/d/html/8093.html" rel="external">"Surgical treatment of benign prostatic hyperplasia (BPH)"</a>.)</p><p class="headingAnchor" id="H2693024991"><span class="h1">RATES OF INCONTINENCE</span><span class="headingEndMark"> — </span>The incidence varies with the definition of incontinence and the method of evaluation. The literature generally uses "pad-free" as a strict definition of continence, but 0 to 1 pads per day has been accepted as a definition of "social continence" [<a href="#rid3">3,4</a>]. </p><p>Immediately following catheter removal after radical prostatectomy (RP), a substantial proportion of men suffer from incontinence. Using 0 to 1 pads per day to define continence, 68.2 percent of men are continent by 3 months, 84 to 91 percent are continent by 12 months, and 93.2 percent are continent by 24 months postoperatively  (<a class="graphic graphic_figure graphicRef127483" href="/z/d/graphic/127483.html" rel="external">figure 1</a>) [<a href="#rid3">3,5,6</a>]. </p><p>Similarly, transient incontinence is not uncommon immediately after surgery for benign prostatic hyperplasia (BPH). The highest rates occur following holmium laser enucleation, occurring in up to 16.2 percent at two weeks postoperatively and declining to 15.1, 11.2, 5.5, and 2.2 percent at 1, 3, 6, and 12 months, respectively [<a href="#rid7">7,8</a>]. Incontinence after simple open prostatectomy ranges from 1 to 8.4 percent [<a href="#rid9">9,10</a>]. Rates of incontinence are lowest following transurethral resection (TURP) or vaporization of the prostate, affecting only 1 to 2 percent of patients long term [<a href="#rid11">11,12</a>]. (See  <a class="medical medical_review" href="/z/d/html/8093.html" rel="external">"Surgical treatment of benign prostatic hyperplasia (BPH)"</a>.)</p><p class="headingAnchor" id="H1306744511"><span class="h1">RISK FACTORS FOR INCONTINENCE</span><span class="headingEndMark"> — </span>Several authors have developed nomograms for predicting return of continence after radical prostatectomy (RP) [<a href="#rid13">13,14</a>]. Relevant risk factors are: </p><p class="bulletIndent1"><span class="glyph">●</span>Preoperative continence status – Preoperative incontinence is the most reliable predictor of incontinence after prostate treatment (IPT). In a survey of 482 men with prostate cancer, 11.9 percent had some degree of urinary leakage at baseline prior to RP [<a href="#rid15">15</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nerve-sparing versus non-nerve-sparing surgery – A prospective study of 3707 patients found that patients who had non-nerve-sparing surgery had a 2.2-fold increased risk of incontinence compared with patients who had a bilateral nerve-sparing dissection at one year postoperatively. This benefit extended to older and impotent men. Thus, it is recommended that in those with favorable pathology on biopsy, nerve sparing should be considered to improve continence rates [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/z/d/html/6944.html" rel="external">"Radical prostatectomy for localized prostate cancer", section on 'Nerve-sparing approach'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Age – Older age is an independent predictor of worsened continence status after RP [<a href="#rid4">4,17,18</a>]. There is increased apoptosis of the striated muscle cells (and associated decreased function) of the external sphincter with age [<a href="#rid19">19</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urethral length – Preoperative membranous urethral length is correlated with continence rates on meta-analysis, with a small but significant improvement with each additional millimeter of length (odds ratio 1.09, 95% CI 1.05-1.15) [<a href="#rid20">20</a>]. Similarly, longer postoperative functional urethral length is also associated with improved continence [<a href="#rid5">5,21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Radiation – Radiation therapy to the prostate, following surgery for either benign or malignant prostate disease, is associated with substantially higher rates of IPT. Patients who have received brachytherapy with or without external beam radiation have incontinence rates of 18 to 70 percent after transurethral resection of the prostate (TURP) [<a href="#rid22">22-24</a>]. Similarly, men who undergo a salvage RP after radiation therapy have worse continence rates (30 to 45 percent) as well as increased risk of bladder neck contracture (30 to 42 percent) compared with men who were not treated with radiation therapy [<a href="#rid25">25,26</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obesity – While patients with an elevated body mass index (BMI) are more likely to have incontinence in the short term, BMI does not predict incontinence at 12 months postoperatively [<a href="#rid27">27,28</a>]. </p><p></p><p class="headingAnchor" id="H3331933627"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Incontinence after prostate treatment (IPT) can result from either bladder or sphincter dysfunction or a combination of the two. </p><p class="headingAnchor" id="H1477267096"><span class="h2">Types of incontinence</span><span class="headingEndMark"> — </span>After prostate surgery, men can develop:</p><p class="bulletIndent1"><span class="glyph">●</span>Stress urinary incontinence (SUI) – Usually due to inadequate urethral sphincter function (see  <a class="medical medical_review" href="/z/d/html/14611.html" rel="external">"Urinary incontinence in men", section on 'Stress urinary incontinence'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urge urinary incontinence (UUI) – Typically associated with either bladder outlet obstruction (BOO) or overactive bladder (OAB) syndrome (see  <a class="medical medical_review" href="/z/d/html/14611.html" rel="external">"Urinary incontinence in men", section on 'Urge urinary incontinence'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Overflow urinary incontinence – Can be due to BOO or detrusor underactivity (see  <a class="medical medical_review" href="/z/d/html/14611.html" rel="external">"Urinary incontinence in men", section on 'Overflow incontinence'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mixed urinary incontinence – A combination of SUI and UUI (see  <a class="medical medical_review" href="/z/d/html/14611.html" rel="external">"Urinary incontinence in men", section on 'Mixed incontinence'</a>)</p><p></p><p class="headingAnchor" id="H2506157241"><span class="h2">Bladder dysfunction</span></p><p class="headingAnchor" id="H790787197"><span class="h3">Overactive</span><span class="headingEndMark"> — </span>The development of de novo irritative symptoms after prostate treatment is common, with approximately one-third of incontinent patients [<a href="#rid29">29-31</a>] having at least some component of overactive bladder symptoms. However, the majority of men with UUI following prostate cancer surgery have concomitant SUI, with only 6 to 7 percent manifesting pure UUI [<a href="#rid29">29,31</a>].</p><p class="headingAnchor" id="H755328916"><span class="h3">Underactive</span><span class="headingEndMark"> — </span>One study found a 33 percent rate of detrusor underactivity in patients who had undergone radical prostatectomy (RP), typically presenting as the complaint of requiring abdominal straining to urinate after the procedure, possibly due to denervation of the trigone [<a href="#rid32">32</a>]. Another study found detrusor underactivity affected 40 percent of men with IPT [<a href="#rid33">33</a>]. </p><p class="headingAnchor" id="H3841564302"><span class="h2">Outlet dysfunction</span></p><p class="headingAnchor" id="H3566355602"><span class="h3">Obstruction</span><span class="headingEndMark"> — </span>A bladder neck contracture (BNC; or vesicourethral anastomotic stricture) is a condition unique to men who have had prostate surgery or radiation that can lead to UUI or to overflow incontinence. The mean time to development of a postoperative stricture is four months, with most men presenting by one year [<a href="#rid34">34</a>]. Contemporary rates of BNC for open RP range from 2.6 to 9 percent, while rates following robotic surgery are lower (0 to 2.1 percent) [<a href="#rid35">35-37</a>]. Rates of BNC after endoscopic procedures for BPH vary but have been reported in as many as 12.3 percent of patients [<a href="#rid38">38,39</a>]. </p><p>In addition to potentially causing overflow incontinence, BNCs are also relevant to the treatment of IPT, especially in the presence of intrinsic sphincter deficiency (ISD), in that the scar from the anastomosis itself may be partly responsible for a poorly coapting intrinsic sphincter. Consequently, BNCs are often seen in conjunction with SUI as well [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H4223306221"><span class="h3">Intrinsic sphincter deficiency</span><span class="headingEndMark"> — </span>ISD is the most common cause of IPT. Following RP, as an example, the vast majority of incontinent men (88 to 100 percent) have ISD as the main cause of their incontinence [<a href="#rid29">29,32,40</a>]. ISD is likely a direct result of the surgery, with injury to the external striated sphincter during ligation of the dorsal venous complex, damage to the smooth muscle of the urethra caused by the anastomotic sutures, and/or denervation due to dissection of the urethra and prostate [<a href="#rid41">41</a>]. </p><p class="headingAnchor" id="H3054409445"><span class="h1">PELVIC FLOOR MUSCLE TRAINING</span><span class="headingEndMark"> — </span>Pelvic floor muscle training (PFMT; practitioner-guided training program) or exercise (PFME; self-guided home exercise program) are recommended prior to and immediately after prostate surgery to enhance continence recovery and may be reinstituted anytime postoperatively when incontinence after prostate treatment (IPT) is established. </p><p class="headingAnchor" id="H3710203917"><span class="h2">Before prostate surgery</span><span class="headingEndMark"> — </span>PFMT or PFME is recommended prior to prostate surgery. Exercises are more easily learned before surgery, as postoperative pain, sensory changes, and muscle inhibition can interfere with compliance [<a href="#rid42">42</a>]. Tactile [<a href="#rid43">43-45</a>], verbal [<a href="#rid43">43,44,46</a>], and visual cues [<a href="#rid44">44</a>] as well as pressure [<a href="#rid47">47</a>], surface electromyography biofeedback [<a href="#rid45">45,46,48</a>], and sonographic imaging [<a href="#rid43">43</a>] are efficacious in teaching men how to isolate and contract their pelvic floor muscles and should start at least three to four weeks preoperatively to allow for neuromuscular adaptation [<a href="#rid43">43-46</a>]. Preoperative PMFT hastens continence recovery after surgery [<a href="#rid43">43,44,47,49</a>].</p><p class="headingAnchor" id="H774897394"><span class="h2">Immediately following prostate surgery</span><span class="headingEndMark"> — </span>PFME is hypothesized to support muscle strength and enhance blood flow to the sphincter to promote continence [<a href="#rid50">50</a>]. Following surgery, PFME should be recommended to all patients upon removal of the urethral catheter, as it has been demonstrated to speed continence recovery compared with control groups [<a href="#rid51">51</a>]. For those patients unable to properly perform pelvic contractions, practitioner-guided PFMT is indicated [<a href="#rid52">52</a>]. Patients can see significant improvements in continence recovery (and improvements in quality of life) in as few as three [<a href="#rid48">48,49,53-55</a>] to six months [<a href="#rid50">50</a>]. While time to continence is shortened, continence rates at one year remain similar between those who did and did not undertake a program of PFME/PFMT [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H4294685541"><span class="h2">Beyond the perioperative period</span><span class="headingEndMark"> — </span>PFME can be efficacious for the patient with established IPT at any point postoperatively. Numerous randomized controlled trials demonstrate the benefits of PFMT [<a href="#rid48">48,49,53,57-60</a>], and supervised PFMT is superior to PFME [<a href="#rid61">61</a>]. It is recommended that all patients with IPT should be encouraged to consider PFMT. Pelvic floor therapy provides patients with an opportunity to participate in and have some control over their health outcomes without risk [<a href="#rid57">57,62</a>]. </p><p class="headingAnchor" id="H2124335826"><span class="h1">EVALUATION OF INCONTINENCE</span></p><p class="headingAnchor" id="H1844199421"><span class="h2">History and physical examination</span><span class="headingEndMark"> — </span>Patient history is critical to identifying the types of incontinence, severity of incontinence, progression or improvement of leakage, and degree of bother, as all of these factors help determine what type of treatment is warranted. </p><p>Specifically, leakage occurring with cough, laugh, sneeze, walking, or other strenuous activity is suggestive of stress urinary incontinence (SUI). While a history of SUI has a 95 percent positive predictive value and 100 percent negative predictive value for the presence of SUI on urodynamic studies [<a href="#rid63">63</a>], the American Urological Association (AUA) guidelines recommend that "clinicians should take all reasonable measures to demonstrate SUI on physical exam [<a href="#rid64">64</a>]." This can be done by observation of leakage with coughing, straining, or positional changes (eg, bending or standing from sitting). (See <a class="local">'Evaluation of sphincter function'</a> below.)</p><p>Leakage associated with sudden desire to void suggests urge urinary incontinence (UUI) [<a href="#rid65">65</a>]. Frequent nocturnal voids and enuresis are more often associated with overactive bladder than with intrinsic sphincter deficiency (ISD). A voiding diary documenting episodes of leakage, fluid intake, and associated urgency can be a useful adjunct to the history [<a href="#rid66">66</a>]. </p><p>Assessment of the severity of leakage and degree of bother from incontinence may guide the shared decision-making process when discussing treatment options. The number of pads per day, size of pads, and wetness of pads have been shown to correlate well with 24 hour pad tests [<a href="#rid67">67</a>]. However, if there is any ambiguity about the severity of leakage, then a formal pad test (one-hour or 24 hour test) can be useful [<a href="#rid68">68</a>]. (See <a class="local">'Pad test'</a> below.)</p><p>Additionally, it is necessary to ascertain if further radiation therapy is likely as this, too, may affect surgical planning and decision making. (See <a class="local">'Risk factors for incontinence'</a> above.)</p><p class="headingAnchor" id="H247863866"><span class="h2">Urodynamics</span><span class="headingEndMark"> — </span>Urodynamics permits better evaluation of sphincter and bladder function. These studies are not routinely recommended for the assessment of SUI, but they may be performed when there is an unclear history of the etiology of incontinence or if there is a discrepancy based on physical examination [<a href="#rid64">64</a>]. (See  <a class="medical medical_review" href="/z/d/html/6879.html" rel="external">"Lower urinary tract symptoms in males", section on 'Diagnostic testing for persistent or complicated symptoms'</a>.)</p><p class="headingAnchor" id="H1956437109"><span class="h3">Evaluation of sphincter function</span><span class="headingEndMark"> — </span>ISD contributes to incontinence after prostate treatment (IPT) in 88 to 100 percent of cases [<a href="#rid5">5,29,40,63,69,70</a>]. Leakage of urine during straining defines the finding of SUI. If the patient does not demonstrate SUI with the urethral catheter in place, the catheter should be removed and the provocative maneuver should be repeated as up to 35 percent of men may not demonstrate SUI while the catheter is in place [<a href="#rid71">71</a>].</p><p class="headingAnchor" id="H4032900071"><span class="h3">Bladder storage and emptying</span><span class="headingEndMark"> — </span>Detrusor overactivity is common in the general adult patient population, and testing in patients prior to prostate surgery has shown preoperative rates of detrusor overactivity between 32 and 55 percent [<a href="#rid72">72,73</a>]. Postoperatively, there is likely a strong association between ISD and detrusor overactivity as detrusor overactivity rarely is an isolated finding [<a href="#rid32">32,73</a>]. Additionally, there is an increase in detrusor underactivity (up to 40 percent) postoperatively [<a href="#rid33">33</a>]. </p><p>Poor bladder compliance is rare in patients after prostate surgery but is a concerning finding given the potential for kidney damage in the setting of high bladder storage pressures. This is most common in patients with neurogenic bladders or severe radiation cystitis [<a href="#rid64">64,74</a>]. Bladder storage pressures should be addressed prior to treatment for the outlet, or patients can undergo periodic surveillance of their upper tracts [<a href="#rid75">75</a>]. </p><p class="headingAnchor" id="H2427296674"><span class="h3">Assess for obstruction</span><span class="headingEndMark"> — </span>Bladder outlet obstruction after prostate surgery is most commonly due to a bladder neck contracture (BNC) in patients who have had a radical prostatectomy (RP), though it may also be due to urethral stricture disease due to prior instrumentation from any prostate surgery or catheterization (see <a class="local">'Obstruction'</a> above). If bladder outlet obstruction is documented on urodynamic study (with high detrusor pressure and low flow on voiding cystometrogram), the next step is a cystoscopy to determine the etiology of the obstruction. </p><p class="headingAnchor" id="H3832921606"><span class="h2">Pad test</span><span class="headingEndMark"> — </span>Pad testing is the gold standard for the quantification of degree of incontinence. The one-hour pad test has been described as a screening tool to determine the presence of incontinence, while the 24 hour pad test is more useful in quantifying the volume of leakage [<a href="#rid76">76-78</a>]. During the one-hour pad test, a patient drinks 500 cc of liquid and then completes various straining maneuvers (walking, standing from sitting, running in place, bending). A pad that weighs over 50 g is considered indicative of severe incontinence [<a href="#rid68">68</a>]. The 24 hour pad test more precisely quantifies the degree of incontinence and can affect surgical decision making, as the upper limit for a recommended sling placement is &lt;200 g per day [<a href="#rid79">79,80</a>]. (See <a class="local">'Volume of leakage determined by pad test'</a> below.)</p><p class="headingAnchor" id="H1607156325"><span class="h2">Cystoscopy with repositioning test</span><span class="headingEndMark"> — </span>Preoperative cystoscopy is necessary to assess the condition of the urethra and the sphincter and to rule out any adverse pathology that may impact the procedure [<a href="#rid64">64</a>]. </p><p>Two specific findings are useful to assess for sufficient residual sphincter function that would suggest the patient is a good candidate for the male sling. First, voluntary contraction of the sphincter can be visualized, and second, a "repositioning test" can be done by compressing and elevating the perineum posterior to the bulbar urethra, which should result in visual coaptation of the membranous urethra [<a href="#rid81">81</a>]. When the clinician gently elevates the perianal perineum, avoiding direct urethral compression [<a href="#rid82">82</a>], sphincteric closure is visible (radiographically or cystoscopically) only in those men with "sufficient residual sphincter function" [<a href="#rid83">83</a>]. </p><p>In addition to the assessment of sphincter function, evaluation of the urethra and bladder neck is important, as stricture disease may complicate artificial urinary sphincter (AUS) placement. (See <a class="local">'Anastomotic stricture/bladder neck contracture'</a> below.)</p><p class="headingAnchor" id="H1806122852"><span class="h2">Cognitive ability and manual dexterity</span><span class="headingEndMark"> — </span>Prior to consideration of AUS implantation, it is necessary to assess if the patient has adequate cognitive and physical ability to operate the device. The patient must be able to cycle the scrotal pump by squeezing it between the index finger and thumb [<a href="#rid64">64</a>]. </p><p class="headingAnchor" id="H931557276"><span class="h1">MANAGEMENT OF INCONTINENCE</span><span class="headingEndMark"> — </span>For patients undergoing incontinence after prostate treatment (IPT) treatment, a shared decision-making process is recommended, whereby the urologist and the patient work together to decide the appropriateness of tests and interventions [<a href="#rid84">84</a>]. Decisions should be based on clinical evidence combined with patient preferences. Such a process yields better health outcomes by reducing anxiety and improving compliance [<a href="#rid85">85-88</a>].</p><p class="headingAnchor" id="H1371736757"><span class="h2">Urge urinary incontinence</span><span class="headingEndMark"> — </span>Management of urge urinary incontinence (UUI) after prostate treatment follows the same algorithm as in patients who have not had surgery or radiation. This is outlined in the American Urological Association and Society of Female Urology and Female Pelvic Medicine and Urogenital Reconstruction guidelines on the diagnosis and treatment of non-neurogenic overactive bladder in adults [<a href="#rid89">89</a>]. (See  <a class="medical medical_review" href="/z/d/html/14611.html" rel="external">"Urinary incontinence in men"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>The first-line therapy is behavioral. (See  <a class="medical medical_review" href="/z/d/html/14611.html" rel="external">"Urinary incontinence in men", section on 'Nonpharmacologic therapy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The second-line treatment includes pharmacotherapy. (See  <a class="medical medical_review" href="/z/d/html/6879.html" rel="external">"Lower urinary tract symptoms in males"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Third-line treatments include sacral neuromodulation, posterior tibial nerve stimulation, and botulinum toxin. (See  <a class="medical medical_review" href="/z/d/html/6879.html" rel="external">"Lower urinary tract symptoms in males"</a>.)</p><p></p><p class="headingAnchor" id="H317766837"><span class="h2">Overflow incontinence</span><span class="headingEndMark"> — </span>In the post-radical prostatectomy (RP) population, overflow incontinence is generally secondary to bladder neck contracture (BNC). BNCs can be managed with dilation, urethrotomy, and, rarely, open revision [<a href="#rid90">90</a>]. The relative timing of BNC and incontinence treatments is discussed below. (See <a class="local">'Anastomotic stricture/bladder neck contracture'</a> below.)</p><p class="headingAnchor" id="H3781363920"><span class="h2">Mixed urinary incontinence</span><span class="headingEndMark"> — </span>As noted above, detrusor overactivity postoperatively is usually found in association with intrinsic sphincter deficiency (ISD) and is rarely an isolated diagnosis [<a href="#rid32">32,73</a>] (see <a class="local">'Bladder storage and emptying'</a> above). Following artificial urinary sphincter (AUS) placement, up to 50 percent of patients with concomitant detrusor overactivity will experience improvement in their overactive bladder symptoms [<a href="#rid91">91</a>]. The presence of concomitant UUI should not prevent surgical treatment of bothersome stress urinary incontinence (SUI). Detrusor overactivity has not been shown to adversely affect outcomes of AUS or sling procedures [<a href="#rid92">92-96</a>]. </p><p class="headingAnchor" id="H1409579423"><span class="h2">Stress urinary incontinence</span><span class="headingEndMark"> — </span>ISD is the most common cause of IPT, usually manifesting as stress incontinence. Treatment of SUI should begin with conservative measures and progress to surgery as needed. </p><p class="headingAnchor" id="H2889757999"><span class="h3">Conservative treatments</span><span class="headingEndMark"> — </span>In the first 6 to 12 months following prostate surgery, conservative treatments are recommended, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Behavioral modification – Including fluid management, bladder retraining, and pelvic floor physiotherapy [<a href="#rid60">60</a>]. (See <a class="local">'Pelvic floor muscle training'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of pads/incontinence briefs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Penile compressive devices – For patients who prefer to use penile compressive devices, the clamp should be released every two hours, the location on the shaft should be varied, and the clamp should not be worn while asleep  (<a class="graphic graphic_figure graphicRef127485" href="/z/d/graphic/127485.html" rel="external">figure 2</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Condom catheters – Condom catheters have a lower risk of urinary tract infection than urethral catheters [<a href="#rid97">97</a>] but must be fitted correctly and may not be able to accommodate all men [<a href="#rid98">98</a>]. (See  <a class="medical medical_review" href="/z/d/html/8090.html" rel="external">"Placement and management of urinary bladder catheters in adults", section on 'External'</a>.)</p><p></p><p>A randomized trial from the United Kingdom compared devices for male continence (pads, condom catheters, penile clamps, and body-worn urinals). While penile clamps were found to be the most secure and least likely to leak, they were also the most uncomfortable. The condom catheter was preferred for extended time periods and its convenience. Pads were preferred for overnight but noted to be uncomfortable when wet. Many patients opted for a combination of options depending on time of day and activity [<a href="#rid99">99</a>]. </p><p>Unfortunately, there is no Food and Drug Administration (FDA)-approved pharmacotherapy for SUI. Alpha-adrenoceptor agonists, beta-2 adrenoceptor agonists, and serotonin-noradrenaline reuptake inhibitors (notably <a class="drug drug_general" data-topicid="8484" href="/z/d/drug information/8484.html" rel="external">duloxetine</a>) have been examined in small nonrandomized studies, but none of these medications are recommended [<a href="#rid100">100</a>]. </p><p class="headingAnchor" id="H383458201"><span class="h3">Surgical options</span><span class="headingEndMark"> — </span>Approximately 5 percent of patients will choose surgery for IPT, typically presenting at a median of 2.9 years after prostate therapy. Surgical options for IPT include AUS, male slings, and periurethral balloons. In a population-based study of RP patients, 2.8 percent of men underwent AUS placement and 1.1 percent underwent male sling placement [<a href="#rid2">2</a>]. </p><p class="headingAnchor" id="H211317021"><span class="h4">Artificial urinary sphincter</span><span class="headingEndMark"> — </span>The AUS is the most predictably reliable treatment for SUI for men with all degrees of incontinence [<a href="#rid101">101-112</a>]. </p><p>The AUS is composed of a circumferential urethral cuff, a pressure-regulating balloon reservoir, and a scrotal pump  (<a class="graphic graphic_figure graphicRef127486" href="/z/d/graphic/127486.html" rel="external">figure 3</a>). It should be placed via a two-incision technique, using a perineal incision for cuff placement and an inguinal incision for balloon reservoir and scrotal pump placement [<a href="#rid113">113,114</a>]. The cuff opens after manual compression of the scrotal pump and automatically closes after a period of two to three minutes. </p><p>The literature is replete with studies demonstrating the efficacy of the AUS in both the short and long term [<a href="#rid101">101-111</a>]. In one large cohort, satisfaction at two years exceeded 90 percent [<a href="#rid105">105</a>]. Specifically, 20 percent of patients never leaked, 55 percent reported leakage of a few drops daily, and 22 percent had leaked less than a teaspoon daily [<a href="#rid105">105</a>]. In another large cohort with up to 11 year follow-up, mean pad use declined 85 percent (4.0 to 0.6 pads per day) following surgery [<a href="#rid106">106</a>].</p><p>Prior to AUS placement, patients must be informed of the risks of mechanical failure, erosion, infection, and persistent incontinence [<a href="#rid105">105,106,109</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Infection and erosion – Infection and erosion are the most common indications for early device explantation. Infection rates are generally less than 5 percent, and urethral cuff erosion occurs at rates between 1 and 10 percent [<a href="#rid111">111,115</a>]. While early erosions are likely related to unrecognized urethral injury during surgery, late erosions are most often related to subsequent urethral instrumentation or catheterization. The presentation of cuff erosion is variable but often includes dysuria and hematuria. The diagnosis is made cystoscopically [<a href="#rid116">116,117</a>]. While the urethral defect typically heals with urethral catheterization, repair of the eroded urethra diminishes subsequent urethral stricture rates [<a href="#rid118">118</a>]. Following AUS erosion/infection, the entire device should be removed, followed by a waiting period of three to six months prior to reimplantation, as washout combined with immediate device replacement has not been proven to be reliably effective [<a href="#rid119">119</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Device failure/persistent incontinence – In the setting of device failure in the absence of infection or erosion, the AUS can be explanted and a new one replaced immediately. The durability and efficacy of a reimplanted device in this setting is the same as that of a primary AUS [<a href="#rid115">115,120,121</a>]. </p><p></p><p class="bulletIndent1">With urethral atrophy, proximal relocation or downsizing of the cuff are both reasonable options that can restore continence. Tandem cuff placement is the addition of a cuff to the original cuff, which is also an effective salvage procedure for patients with persistent incontinence. However, initial tandem cuff placement is not recommended, as a review showed equivalent continence outcomes but a complication rate four times higher in the tandem cuff group [<a href="#rid122">122,123</a>]. Other options include replacing the pressure-regulating balloon with a higher-pressure system and using a transcorporal cuff placement to improve urethral coaptation, especially in the setting of prior radiation and/or erosion. With this technique, the urethral cuff is tunneled through the erectile bodies, whereby the tunica albuginea protects the dorsal aspect of the urethra.</p><p></p><p class="bulletIndent1">In general, the efficacy and durability after secondary AUS placement for device failure appear to be similar to that after primary AUS placement, despite a slightly higher rate of cuff erosion [<a href="#rid115">115,120,121</a>]. Patient satisfaction relates more to continence status after AUS than to the number of reoperations [<a href="#rid109">109,124</a>]. </p><p></p><p class="headingAnchor" id="H2857069772"><span class="h4">Male sling</span><span class="headingEndMark"> — </span>Male slings are recommended for nonradiated patients who have mild-to-moderate SUI after prostate surgery [<a href="#rid64">64</a>], and success rates are highest in men with pad weights &lt;200 g per day [<a href="#rid125">125,126</a>]. (See <a class="local">'Pad test'</a> above and <a class="local">'Volume of leakage determined by pad test'</a> below.)</p><p>A male sling is a procedure where mesh is placed under the urethra to relocate the proximal urethra and/or compress the bulbous urethra [<a href="#rid127">127</a>]. This procedure is minimally invasive and can be an attractive option for men who would like to avoid a mechanical device  (<a class="graphic graphic_figure graphicRef127487" href="/z/d/graphic/127487.html" rel="external">figure 4</a>). </p><p>There are three type of male slings:</p><p class="bulletIndent1"><span class="glyph">●</span>Transobturator – The transobturator sling is a noncompressive sling that functions to relocate the proximal urethra closer to the sphincter complex and lengthen the membranous urethra [<a href="#rid82">82</a>]. The sling is placed perineally, via an outside-in transobturator approach. The sling is attached to the urethra, and, with proper tensioning, the bulbous urethra is repositioned approximately 2 to 2.5 cm proximally. Cystourethroscopy confirms coaptation of the membranous urethra [<a href="#rid128">128</a>]. </p><p></p><p class="bulletIndent1">Patients who undergo transobturator male sling placement have a 62 percent cure rate (range 34 to 91 percent) when defined as a negative one-hour pad test or 0 to 1 pads per day, and an additional 34 percent are improved [<a href="#rid64">64</a>]. In general, these patients had no prior radiation and &lt;500 g (or &lt; 5 pads) of daily leakage. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Quadratic – The quadratic sling acts to both relocate the proximal urethra and compress the ventral urethra [<a href="#rid129">129</a>]. The sling is placed perineally via an inside-out transobturator approach, combined with a prepubic component that allows for compression of the distal bulbous urethra in addition to proximal relocation of the sphincter complex. The prepubic arms are then secured to the periosteum of the inferior pubic rami, and the transobturator arms are tunneled subcutaneously back to the perineal incision to facilitate adequate sling tensioning [<a href="#rid130">130</a>]. </p><p></p><p class="bulletIndent1">The quadratic sling with fixation is associated with similar success rates compared with transobturator slings, with a cure rate of 46 percent and cure/improvement rate of 79.2 percent at 12 months [<a href="#rid131">131</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adjustable – Adjustable male slings are not currently approved for use in the United States (US). Adjustable slings have the ability to be altered to optimize continence or to prevent retention of urine at the expense of a higher explantation rate in some systems [<a href="#rid132">132,133</a>]. Risk factors associated with failure for the adjustable slings are similar to those for the fixed resistance slings [<a href="#rid134">134</a>], and overall success rates are also similar between fixed and adjustable devices [<a href="#rid127">127,135</a>]. </p><p></p><p>Complication rates after male sling are low. Complications include urethral injury during trocar passage, transient urinary retention (0 to 30 percent) [<a href="#rid80">80,136,137</a>], and transient pelvic, perineal, or scrotal pain (0 to 20 percent) [<a href="#rid79">79,137,138</a>]. Pain and retention nearly always resolve (&gt;98 percent resolution) with conservative management for both fixed and adjustable slings [<a href="#rid133">133</a>].</p><p class="headingAnchor" id="H2359994607"><span class="h4">Periurethral balloons</span><span class="headingEndMark"> — </span>While periurethral balloons are most appropriate in patients with mild SUI [<a href="#rid64">64</a>], there are two reports demonstrating efficacy of the ProACT device in patients with moderate-to-severe SUI [<a href="#rid139">139,140</a>]. Radiation is a contraindication to placement due to an increased risk of balloon migration and fibrosis [<a href="#rid141">141</a>].</p><p>Periurethral adjustable balloon placement is a minimally invasive placement of two silicone balloons near the bladder neck for external compression of the prostate. The bladder is filled with contrast to opacify the bladder and bladder neck. The balloons are placed just distal to the bladder neck and passed percutaneously via the perineum under fluoroscopic guidance [<a href="#rid142">142</a>] or under transrectal ultrasound guidance [<a href="#rid121">121</a>]. Ports connected to the balloons are buried superficially to allow for adjustment in balloon volume as needed percutaneously.</p><p>A systematic review and meta-analysis of the ProACT device reported a dry rate of 60.2 percent and a dry or improvement rate of 81.2 percent. Patients required on average 3.2 adjustments [<a href="#rid143">143</a>]. In a comparative trial, the adjustable sling had higher cure rates (68 versus 55 percent, p = 0.01) and lower explantation rates than the ProACT device (5 versus 24 percent, p &lt;0.001) [<a href="#rid144">144</a>]. </p><p>Complication and revision rates for the ProACT device are higher than those for slings. Immediate complications include bladder and urethral perforation (5.3 percent), infection (2.2 percent), and urinary retention (1.5 percent). The overall revision rate was 22.2 percent over a mean of 3.6 years of follow-up for erosions, device leakage, and device migration in the meta-analysis [<a href="#rid143">143</a>]. </p><p class="headingAnchor" id="H3513089782"><span class="h3">Initial surgical treatment</span><span class="headingEndMark"> — </span>The decision to have surgery for IPT, and which procedure to choose, is based on a shared decision-making model, whereby the clinician informs the patient of the risks, benefits, expectations, and alternatives for the recommended surgical choices, taking into considerations the patient's understanding, beliefs, and preferences. The initial surgical treatment is selected based on the following considerations:</p><p class="headingAnchor" id="H369418671"><span class="h4">Sling versus AUS</span><span class="headingEndMark"> — </span>The transobturator male sling and the AUS were compared in a prospective randomized trial (MASTER) of 380 men with urodynamically demonstrated stress incontinence after prostate surgery [<a href="#rid145">145</a>]. Using a strict definition of success as lack of "any leakage of urine," male sling had a 13 percent dry rate versus 16 percent for the AUS. Using a slightly less strict definition, "leakage less than once per week," 34 percent of male sling versus 35 percent of AUS recipients achieved continence at 12 months after surgery. Nevertheless, the subjective degree of urinary incontinence was greatly reduced after both procedures. Preoperative pad weight was measured in all patients but was not evaluated in most patients postoperatively, which limited objective outcome assessment. While subgroup analyses of greater urinary incontinence at baseline (&gt;250 g pad weight) favored AUS, the study was insufficiently powered to show a difference in outcomes based on preoperative pad weight. Patient satisfaction was greater in the AUS group compared with the sling group (90.6 versus 72.2 percent, p &lt;0.001). Based on a multitude of nonrandomized studies demonstrating a higher likelihood of objective sling success in men with &lt;200 g on 24 hour pad weight, we still favor AUS for men with baseline incontinence &gt;200 g on 24 hour pad weight but agree with the authors of the MASTER trial that surgical selection should be based on a discussion regarding the risks and benefits of the AUS and various sling options. </p><p class="headingAnchor" id="H2467240162"><span class="h4">Tissue compliance determined by the repositioning test</span><span class="headingEndMark"> — </span>When deciding if a male sling is likely to succeed, it is important to understand that adequate tissue compliance is necessary for successful urethral compression and/or proximal repositioning with a sling. (See <a class="local">'Cystoscopy with repositioning test'</a> above.)</p><p>By reflecting the degree of residual sphincter function, a positive repositioning test is associated with a surgical success rate &gt;80 percent, while only 25 percent of patients with a negative test were cured [<a href="#rid146">146-148</a>]. Following a negative repositioning test, the patient should be offered AUS implantation. </p><p class="headingAnchor" id="H3639673227"><span class="h4">Volume of leakage determined by pad test</span><span class="headingEndMark"> — </span>Another risk factor for sling failure is high-volume leakage. One study showed for each 1 g increase in preoperative 24 hour pad weight, cure rate decreased by 0.4 percent [<a href="#rid149">149</a>]. </p><p>Two large cohort studies demonstrated that the transobturator sling performs best in patients with a leaked volume of &lt;200 g/day [<a href="#rid125">125,126</a>]. The multinational trial of the quadratic sling with fixation did not show a difference in success rates based on pad weight, likely due to the additive efficacy provided by the prepubic component in addition to the transobturator repositioning. In that study, objective success (79 percent) and subjective success (71 percent) were achieved even in men with &gt;400 g/day of leakage [<a href="#rid131">131</a>]. Another study corroborated the efficacy of the quadratic sling up to three years out, with 25/29 patients rating their outcome as "very much improved" by Patient Global Impression of Improvement (PGI-I) questionnaire [<a href="#rid150">150</a>]. However, that study excluded patients with severe incontinence. (See <a class="local">'Male sling'</a> above.)</p><p>Based on the preponderance of evidence, it is generally recommended that the male sling be reserved for patients with mild-to-moderate SUI, with pad use &lt;3 pads per day or &lt;200 g per day, while those with more significant leakage are more appropriately treated by implantation of a circumferential AUS. </p><p class="headingAnchor" id="H1950734954"><span class="h4">Prior radiation therapy or explanted AUS</span><span class="headingEndMark"> — </span>Not surprisingly, prior AUS explantation and external beam or interstitial radiation [<a href="#rid127">127,132,134</a>] are predictive of diminished efficacy for most male slings, as radiation and fibrosis create a poorly compliant and relatively noncompressible urethra. Specifically, the success rate in men with radiation has been reported to be as low as 0 to 25 percent cure, with 29 to 50 percent improvement versus &gt;80 percent cure in a nonradiated comparable cohort [<a href="#rid126">126,151</a>]. Therefore, AUS is the treatment of choice in this population with IPT.  </p><p class="headingAnchor" id="H2050491634"><span class="h4">Comorbidities</span><span class="headingEndMark"> — </span>Two cohort studies found that a poor Charleston Comorbidity Index [<a href="#rid152">152</a>] and higher American Society of Anesthesiologists (ASA) class [<a href="#rid153">153</a>] predicted adverse outcomes for the male sling and AUS, respectively. There is not sufficient information regarding the effect of comorbidities on the outcome of periurethral balloon surgery.</p><p class="headingAnchor" id="H305595394"><span class="h4">SUI following BPH surgery</span><span class="headingEndMark"> — </span>The rate of bothersome SUI following surgical management for benign prostatic hyperplasia (BPH) typically ranges from 0 to 8.4 percent [<a href="#rid10">10,154</a>]. Transurethral resection of the prostate (TURP) following external beam or interstitial radiation has a substantially higher risk of SUI compared with TURP in the nonradiated patient, with incontinence rates up to 70 percent [<a href="#rid22">22,24</a>], and the risk increases with the number of surgeries [<a href="#rid155">155</a>]. </p><p>The evaluation of such patients should be similar to that for post-RP SUI, including consideration of bladder dysfunction as a contributing factor. If conservative management is unsuccessful, then surgery is indicated. Male sling and AUS surgery are safe and efficacious in men with SUI after BPH treatment, with results similar to those published for post-RP SUI surgery [<a href="#rid10">10,156,157</a>]. For those men with post-TURP SUI who have a history of radiation therapy, AUS is the treatment of choice.</p><p class="headingAnchor" id="H110333073"><span class="h4">Sexual arousal incontinence and climacturia</span><span class="headingEndMark"> — </span>Leakage during sexual activity affects an average of 30 percent of patients following prostate cancer surgery, with reported ranges of 20 to 93 percent [<a href="#rid158">158</a>]. One-third of men with this disorder report avoiding sexual situations secondary to fear of leakage [<a href="#rid159">159</a>]. Leakage during sexual arousal relates to ISD, while incontinence during orgasms likely involves an uninhibited bladder contraction at the time of orgasm in conjunction with external sphincter weakness [<a href="#rid160">160</a>].</p><p>Conservative treatment is recommended initially, with behavioral management (voiding prior to sex, condom use). Pelvic floor muscle exercises have also shown efficacy [<a href="#rid45">45</a>]. A variable-tension soft silicone loop placed around the penis during sex has demonstrated efficacy, decreasing the reported bother in patients and partners, from 14 and 61 percent to 2 and 11 percent, respectively [<a href="#rid161">161</a>]. Surgical success with male sling or AUS mirrors that for SUI surgery in general [<a href="#rid162">162,163</a>]. </p><p class="headingAnchor" id="H126752215"><span class="h4">Concomitant refractory erectile dysfunction</span><span class="headingEndMark"> — </span>For men who have SUI and erectile dysfunction (ED) refractory to medical management, concomitant penile prosthesis and AUS can be offered. There are conflicting data on the infection risk and complication rate of staged versus combined procedures. In a Surveillance, Epidemiology, and End Results Medicare database study, there was no difference between the 90 day complication rate of a combined AUS/penile prosthesis implant and that of an AUS or a penile prosthesis alone [<a href="#rid164">164</a>]. Similarly, in another study, a combined implantation was not associated with an increased rate of device infection, erosion, or malfunction with over 1.5 years of follow-up [<a href="#rid165">165</a>]. </p><p class="headingAnchor" id="H579876059"><span class="h4">Anastomotic stricture/bladder neck contracture</span><span class="headingEndMark"> — </span>The relative timing of BNC and incontinence treatments can be challenging, but a staged approach is generally recommended, with initial treatment of the symptomatic BNC and delay of incontinence treatment surgery for four to six weeks after assuring that the BNC has not recurred [<a href="#rid166">166,167</a>]. However, in a study of a heterogeneous population of patients with incontinence and BNC after RP, for the patients with an asymptomatic BNC diagnosed on preoperative cystoscopy, a simultaneous incision of the BNC and AUS placement was performed. None of these patients required a re-incision of the BNC with an average follow-up of 26.6 months [<a href="#rid168">168</a>]. </p><p class="headingAnchor" id="H256726502"><span class="h3">Salvage surgical treatment</span><span class="headingEndMark"> — </span>When a patient develops recurrent SUI after previously having a good result of an AUS or sling, reevaluation with history, physical examination, and urodynamics is indicated to determine the specific pathophysiology surrounding the incontinence (eg, detrusor overactivity, persistent ISD, decreased bladder compliance). Additionally, strong consideration should be made to perform a cystoscopy to evaluate for device erosion. (See <a class="local">'Evaluation of incontinence'</a> above.)</p><p class="headingAnchor" id="H2990351843"><span class="h4">Following AUS</span><span class="headingEndMark"> — </span>With recurrent incontinence after AUS, the device should be cycled by the urologist to assess functionality. An imaging study can be used to verify the presence of fluid in the reservoir to rule out a leak. During exploration, if a leak is confined to one part of the device, the remaining components may be left in situ if they were placed within the prior two years [<a href="#rid111">111,115,169,170</a>]. In the case of urethral atrophy causing recurrent SUI, a tandem cuff can be placed, the cuff can be downsized or repositioned proximally, or, alternatively, a higher-pressure balloon reservoir can be inserted [<a href="#rid171">171</a>]. Efficacy after secondary AUS placement is similar to that for primary AUS [<a href="#rid115">115,120,121</a>]. (See <a class="local">'Artificial urinary sphincter'</a> above.)</p><p class="headingAnchor" id="H3117542324"><span class="h4">Following sling</span><span class="headingEndMark"> — </span>With persistent or recurrent incontinence following male sling surgery, the surgical choices are repeat sling versus AUS implantation. </p><p class="headingAnchor" id="H2998604593"><span class="h5">Repeat sling</span><span class="headingEndMark"> — </span>Only in carefully selected patients should a repeat sling be offered. In a report of 33 patients who received repeat transobturator sling following failed prior sling, the cure/1 pad per day rate was 79 percent at 6 months and 72 percent at 17 months, but it must be noted that these patients were carefully selected and only offered repeat sling if they demonstrated a positive repositioning test, while those with fixed or scarred external urethral sphincter were excluded [<a href="#rid172">172</a>]. Another study demonstrated a 72 percent success rate at 6 months versus 56 percent success rate at 17 months with repeat sling and noted that patients with early sling failure (&lt;6 months) were less likely to achieve continence upon repeat surgery [<a href="#rid173">173</a>].</p><p>In a cohort of 30 patients who failed prior incontinence surgery, implantation of an adjustable male sling was associated with a satisfaction rate of 83 percent at 24 months [<a href="#rid174">174</a>]. </p><p class="headingAnchor" id="H2531141238"><span class="h5">Implanting AUS in patient with in situ sling</span><span class="headingEndMark"> — </span>While a secondary sling can be performed with success in highly selected patients at experienced centers [<a href="#rid147">147,172</a>], it is generally agreed that the most efficacious treatment option is AUS implantation. In a cohort of 61 men who failed transobturator sling, 29 underwent repeat sling and 32 underwent AUS implantation. In the group that had AUS placed, only 6 percent failed, compared with 55 percent who failed repeat sling [<a href="#rid175">175</a>]. </p><p>AUS after sling has a similarly excellent success rate compared with primary AUS [<a href="#rid176">176,177</a>]. In men treated with a male sling, 13 percent will ultimately undergo secondary AUS implantation [<a href="#rid178">178</a>]. With prior transobturator sling, the AUS cuff can be placed distal to the previous sling, which neither renders the operation more difficult nor decreases AUS efficacy [<a href="#rid127">127,179</a>]. With prior quadratic sling, the polypropylene sling is readily identified and dissected off the underlying muscle or urethra, and the AUS may be placed in routine fashion [<a href="#rid180">180</a>]. </p><p class="headingAnchor" id="H1314216724"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/109273.html" rel="external">"Society guideline links: Urinary incontinence in adults"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/117831.html" rel="external">"Society guideline links: Diagnosis and management of prostate cancer"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/116802.html" rel="external">"Society guideline links: Benign prostatic hyperplasia"</a>.)</p><p class="headingAnchor" id="H3575223113"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incidence </strong>– Incontinence after prostate treatment (IPT) has an incidence of &lt;2 percent after endoscopic management of benign prostatic hyperplasia (BPH) and 9 to 16 percent at one year after radical prostatectomy (RP). The rates of incontinence generally decrease over the first year. (See <a class="local">'Introduction'</a> above and <a class="local">'Rates of incontinence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathophysiology and risk factors</strong> – Men can develop both stress urinary incontinence and urge urinary incontinence after RP. Risk factors for IPT include preoperative incontinence, older age, non-nerve-sparing surgery, radiation, and shorter urethral length. (See <a class="local">'Pathophysiology'</a> above and <a class="local">'Risk factors for incontinence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pelvic floor muscle training</strong> – For patients undergoing prostate treatment, we suggest pelvic floor muscle training/exercise rather than observation (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). It should be started at least three to four weeks prior to prostate surgery and can be continued immediately after surgery or whenever IPT is diagnosed. (See <a class="local">'Pelvic floor muscle training'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation of incontinence</strong> – History with an emphasis on the type of leakage and activity associated with leakage and a physical examination demonstrating stress urinary incontinence are key to the preoperative workup. A cystoscopy is also recommended to rule out bladder/urethral pathology and facilitate the repositioning test. A pad test can quantify the degree of incontinence. Urodynamic studies are only needed when there is an unclear history, when the physical examination is not consistent with the given history, or when obstruction is suspected. (See <a class="local">'Evaluation of incontinence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of incontinence </strong>–<strong> </strong>(See <a class="local">'Management of incontinence'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Urge incontinence</strong> – Urge urinary incontinence should be treated with behavioral modification, pelvic floor muscle exercises, and anticholinergics/beta-3 agonists, followed by chemodenervation or neuromodulation as necessary. This treatment regimen is the same for IPT as for urinary incontinence due to other etiologies. (See  <a class="medical medical_review" href="/z/d/html/14611.html" rel="external">"Urinary incontinence in men", section on 'Urge urinary incontinence'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Stress incontinence</strong> – Stress urinary incontinence in IPT patients should be initially managed with behavioral modification, pelvic floor muscle training/exercises, and pads/incontinence briefs/penile clamps/condom catheters until 6 to 12 months postoperatively. (See <a class="local">'Conservative treatments'</a> above.)</p><p></p><p class="bulletIndent2">Surgical options for stress urinary incontinence in IPT patients include the following (see <a class="local">'Surgical options'</a> above): </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The artificial urinary sphincter is the most predictably reliable surgery for all types of incontinence. (See <a class="local">'Artificial urinary sphincter'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Male slings are more effective with mild-to-moderate stress urinary incontinence (with pad use &lt;3 pads per day or &lt;200 g per day) and no history of radiation. (See <a class="local">'Male sling'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Periurethral balloons are an effective minimally invasive option for men with mild-to-moderate stress urinary incontinence but who have a high revision and complication rate. (See <a class="local">'Periurethral balloons'</a> above.)</p><p></p><p class="bulletIndent2">There are a number of special considerations for patients when deciding to use a sling versus an artificial urinary sphincter device, including history of radiation, severity of leakage, detrusor contractility, prior treatment, and the presence of a vesicourethral anastomotic stricture. (See <a class="local">'Initial surgical treatment'</a> above and <a class="local">'Salvage surgical treatment'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 2005; 23:2772.</a></li><li><a class="nounderline abstract_t">Nam RK, Herschorn S, Loblaw DA, et al. Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancer. J Urol 2012; 188:502.</a></li><li><a class="nounderline abstract_t">Sacco E, Prayer-Galetti T, Pinto F, et al. Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up. BJU Int 2006; 97:1234.</a></li><li><a class="nounderline abstract_t">Ficarra V, Novara G, Rosen RC, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2012; 62:405.</a></li><li><a class="nounderline abstract_t">Hammerer P, Huland H. Urodynamic evaluation of changes in urinary control after radical retropubic prostatectomy. J Urol 1997; 157:233.</a></li><li><a class="nounderline abstract_t">Donnellan SM, Duncan HJ, MacGregor RJ, Russell JM. Prospective assessment of incontinence after radical retropubic prostatectomy: objective and subjective analysis. Urology 1997; 49:225.</a></li><li><a class="nounderline abstract_t">Cho MC, Park JH, Jeong MS, et al. Predictor of de novo urinary incontinence following holmium laser enucleation of the prostate. Neurourol Urodyn 2011; 30:1343.</a></li><li><a class="nounderline abstract_t">Large T, Krambeck AE. Evidence-based outcomes of holmium laser enucleation of the prostate. Curr Opin Urol 2018; 28:301.</a></li><li><a class="nounderline abstract_t">Garcia-Segui A, Angulo JC. Prospective study comparing laparoscopic and open adenomectomy: Surgical and functional results. Actas Urol Esp 2017; 41:47.</a></li><li><a class="nounderline abstract_t">Silva LA, Andriolo RB, Atallah ÁN, da Silva EM. Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery. Cochrane Database Syst Rev 2014; :CD008306.</a></li><li><a class="nounderline abstract_t">Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol 2006; 50:969.</a></li><li><a class="nounderline abstract_t">Bae J, Kang HW, Lee HW, et al. Predictors of de novo urge urinary incontinence after photoselective vaporization of the prostate. World J Urol 2016; 34:413.</a></li><li><a class="nounderline abstract_t">Jeong SJ, Yeon JS, Lee JK, et al. Development and validation of nomograms to predict the recovery of urinary continence after radical prostatectomy: comparisons between immediate, early, and late continence. World J Urol 2014; 32:437.</a></li><li><a class="nounderline abstract_t">Matsushita K, Kent MT, Vickers AJ, et al. Preoperative predictive model of recovery of urinary continence after radical prostatectomy. BJU Int 2015; 116:577.</a></li><li><a class="nounderline abstract_t">Wei JT, Dunn RL, Marcovich R, et al. Prospective assessment of patient reported urinary continence after radical prostatectomy. J Urol 2000; 164:744.</a></li><li><a class="nounderline abstract_t">Steineck G, Bjartell A, Hugosson J, et al. Degree of preservation of the neurovascular bundles during radical prostatectomy and urinary continence 1 year after surgery. Eur Urol 2015; 67:559.</a></li><li><a class="nounderline abstract_t">Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000; 283:354.</a></li><li><a class="nounderline abstract_t">Lardas M, Grivas N, Debray TPA, et al. Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus 2022; 8:674.</a></li><li><a class="nounderline abstract_t">Strasser H, Tiefenthaler M, Steinlechner M, et al. Urinary incontinence in the elderly and age-dependent apoptosis of rhabdosphincter cells. Lancet 1999; 354:918.</a></li><li><a class="nounderline abstract_t">Mungovan SF, Sandhu JS, Akin O, et al. Preoperative Membranous Urethral Length Measurement and Continence Recovery Following Radical Prostatectomy: A Systematic Review and Meta-analysis. Eur Urol 2017; 71:368.</a></li><li><a class="nounderline abstract_t">Colarieti A, Thiruchelvam N, Barrett T. Evaluation of image-based prognostic parameters of post-prostatectomy urinary incontinence: A literature review. Int J Urol 2021; 28:890.</a></li><li><a class="nounderline abstract_t">Mock S, Leapman M, Stock RG, et al. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters. J Urol 2013; 190:1805.</a></li><li><a class="nounderline abstract_t">Kollmeier MA, Stock RG, Cesaretti J, Stone NN. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy. J Urol 2005; 173:808.</a></li><li><a class="nounderline abstract_t">Hu K, Wallner K. Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy. Int J Radiat Oncol Biol Phys 1998; 40:783.</a></li><li><a class="nounderline abstract_t">Yuh B, Ruel N, Muldrew S, et al. Complications and outcomes of salvage robot-assisted radical prostatectomy: a single-institution experience. BJU Int 2014; 113:769.</a></li><li><a class="nounderline abstract_t">Stephenson AJ, Scardino PT, Bianco FJ Jr, et al. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 2004; 172:2239.</a></li><li><a class="nounderline abstract_t">Kadono Y, Ueno S, Kadomoto S, et al. Use of preoperative factors including urodynamic evaluations and nerve-sparing status for predicting urinary continence recovery after robot-assisted radical prostatectomy: Nerve-sparing technique contributes to the reduction of postprostatectomy incontinence. Neurourol Urodyn 2016; 35:1034.</a></li><li><a class="nounderline abstract_t">Mandel P, Kretschmer A, Chandrasekar T, et al. The effect of BMI on clinicopathologic and functional outcomes after open radical prostatectomy. Urol Oncol 2014; 32:297.</a></li><li><a class="nounderline abstract_t">Groutz A, Blaivas JG, Chaikin DC, et al. The pathophysiology of post-radical prostatectomy incontinence: a clinical and video urodynamic study. J Urol 2000; 163:1767.</a></li><li><a class="nounderline abstract_t">Matsukawa Y, Yoshino Y, Ishida S, et al. De novo overactive bladder after robot-assisted laparoscopic radical prostatectomy. Neurourol Urodyn 2018; 37:2008.</a></li><li><a class="nounderline abstract_t">Hosier GW, Tennankore KK, Himmelman JG, et al. Overactive Bladder and Storage Lower Urinary Tract Symptoms Following Radical Prostatectomy. Urology 2016; 94:193.</a></li><li><a class="nounderline abstract_t">Kielb SJ, Clemens JQ. Comprehensive urodynamics evaluation of 146 men with incontinence after radical prostatectomy. Urology 2005; 66:392.</a></li><li><a class="nounderline abstract_t">Elliott CS, Comiter CV. Maximum isometric detrusor pressure to measure bladder strength in men with postprostatectomy incontinence. Urology 2012; 80:1111.</a></li><li><a class="nounderline abstract_t">Park R, Martin S, Goldberg JD, Lepor H. Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence. Urology 2001; 57:742.</a></li><li><a class="nounderline abstract_t">Wang R, Wood DP Jr, Hollenbeck BK, et al. Risk factors and quality of life for post-prostatectomy vesicourethral anastomotic stenoses. Urology 2012; 79:449.</a></li><li><a class="nounderline abstract_t">Webb DR, Sethi K, Gee K. An analysis of the causes of bladder neck contracture after open and robot-assisted laparoscopic radical prostatectomy. BJU Int 2009; 103:957.</a></li><li><a class="nounderline abstract_t">Breyer BN, Davis CB, Cowan JE, et al. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int 2010; 106:1734.</a></li><li><a class="nounderline abstract_t">Puppo P, Bertolotto F, Introini C, et al. Bipolar transurethral resection in saline (TURis): outcome and complication rates after the first 1000 cases. J Endourol 2009; 23:1145.</a></li><li><a class="nounderline abstract_t">Lee YH, Chiu AW, Huang JK. Comprehensive study of bladder neck contracture after transurethral resection of prostate. Urology 2005; 65:498.</a></li><li><a class="nounderline abstract_t">Chao R, Mayo ME. Incontinence after radical prostatectomy: detrusor or sphincter causes. J Urol 1995; 154:16.</a></li><li class="breakAll">Schaeffer EM, Partin AW, Lepor H. Open radical prostatectomy. In: Campbell-Walsh Urology, Wein AJ, Kavoussi LR, Partin AW, Peters CA (Eds), Elsevier, Philadelphia 2016. p.2641.</li><li><a class="nounderline abstract_t">Manassero F, Traversi C, Ales V, et al. Contribution of early intensive prolonged pelvic floor exercises on urinary continence recovery after bladder neck-sparing radical prostatectomy: results of a prospective controlled randomized trial. Neurourol Urodyn 2007; 26:985.</a></li><li><a class="nounderline abstract_t">Patel MI, Yao J, Hirschhorn AD, Mungovan SF. Preoperative pelvic floor physiotherapy improves continence after radical retropubic prostatectomy. Int J Urol 2013; 20:986.</a></li><li><a class="nounderline abstract_t">Centemero A, Rigatti L, Giraudo D, et al. Preoperative pelvic floor muscle exercise for early continence after radical prostatectomy: a randomised controlled study. Eur Urol 2010; 57:1039.</a></li><li><a class="nounderline abstract_t">Geraerts I, Van Poppel H, Devoogdt N, et al. Pelvic floor muscle training for erectile dysfunction and climacturia 1 year after nerve sparing radical prostatectomy: a randomized controlled trial. Int J Impot Res 2016; 28:9.</a></li><li><a class="nounderline abstract_t">Bales GT, Gerber GS, Minor TX, et al. Effect of preoperative biofeedback/pelvic floor training on continence in men undergoing radical prostatectomy. Urology 2000; 56:627.</a></li><li><a class="nounderline abstract_t">Burgio KL, Goode PS, Urban DA, et al. Preoperative biofeedback assisted behavioral training to decrease post-prostatectomy incontinence: a randomized, controlled trial. J Urol 2006; 175:196.</a></li><li><a class="nounderline abstract_t">Parekh AR, Feng MI, Kirages D, et al. The role of pelvic floor exercises on post-prostatectomy incontinence. J Urol 2003; 170:130.</a></li><li><a class="nounderline abstract_t">Tienforti D, Sacco E, Marangi F, et al. Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial. BJU Int 2012; 110:1004.</a></li><li><a class="nounderline abstract_t">Overgård M, Angelsen A, Lydersen S, Mørkved S. Does physiotherapist-guided pelvic floor muscle training reduce urinary incontinence after radical prostatectomy? A randomised controlled trial. Eur Urol 2008; 54:438.</a></li><li><a class="nounderline abstract_t">Fernández RA, García-Hermoso A, Solera-Martínez M, et al. Improvement of continence rate with pelvic floor muscle training post-prostatectomy: a meta-analysis of randomized controlled trials. Urol Int 2015; 94:125.</a></li><li><a class="nounderline abstract_t">Hodges PW, Stafford RE, Hall L, et al. Reconsideration of pelvic floor muscle training to prevent and treat incontinence after radical prostatectomy. Urol Oncol 2020; 38:354.</a></li><li><a class="nounderline abstract_t">Mariotti G, Sciarra A, Gentilucci A, et al. Early recovery of urinary continence after radical prostatectomy using early pelvic floor electrical stimulation and biofeedback associated treatment. J Urol 2009; 181:1788.</a></li><li><a class="nounderline abstract_t">Marchiori D, Bertaccini A, Manferrari F, et al. Pelvic floor rehabilitation for continence recovery after radical prostatectomy: role of a personal training re-educational program. Anticancer Res 2010; 30:553.</a></li><li><a class="nounderline abstract_t">Van Kampen M, De Weerdt W, Van Poppel H, et al. Effect of pelvic-floor re-education on duration and degree of incontinence after radical prostatectomy: a randomised controlled trial. Lancet 2000; 355:98.</a></li><li><a class="nounderline abstract_t">Anderson CA, Omar MI, Campbell SE, et al. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev 2015; 1:CD001843.</a></li><li><a class="nounderline abstract_t">Moore KN, Valiquette L, Chetner MP, et al. Return to continence after radical retropubic prostatectomy: a randomized trial of verbal and written instructions versus therapist-directed pelvic floor muscle therapy. Urology 2008; 72:1280.</a></li><li><a class="nounderline abstract_t">Floratos DL, Sonke GS, Rapidou CA, et al. Biofeedback vs verbal feedback as learning tools for pelvic muscle exercises in the early management of urinary incontinence after radical prostatectomy. BJU Int 2002; 89:714.</a></li><li><a class="nounderline abstract_t">Ribeiro LH, Prota C, Gomes CM, et al. Long-term effect of early postoperative pelvic floor biofeedback on continence in men undergoing radical prostatectomy: a prospective, randomized, controlled trial. J Urol 2010; 184:1034.</a></li><li><a class="nounderline abstract_t">Goode PS, Burgio KL, Johnson TM 2nd, et al. Behavioral therapy with or without biofeedback and pelvic floor electrical stimulation for persistent postprostatectomy incontinence: a randomized controlled trial. JAMA 2011; 305:151.</a></li><li><a class="nounderline abstract_t">Baumann FT, Reimer N, Gockeln T, et al. Supervised pelvic floor muscle exercise is more effective than unsupervised pelvic floor muscle exercise at improving urinary incontinence in prostate cancer patients following radical prostatectomy - a systematic review and meta-analysis. Disabil Rehabil 2022; 44:5374.</a></li><li><a class="nounderline abstract_t">Wille S, Sobottka A, Heidenreich A, Hofmann R. Pelvic floor exercises, electrical stimulation and biofeedback after radical prostatectomy: results of a prospective randomized trial. J Urol 2003; 170:490.</a></li><li><a class="nounderline abstract_t">Ficazzola MA, Nitti VW. The etiology of post-radical prostatectomy incontinence and correlation of symptoms with urodynamic findings. J Urol 1998; 160:1317.</a></li><li><a class="nounderline abstract_t">Sandhu JS, Breyer B, Comiter C, et al. Incontinence after Prostate Treatment: AUA/SUFU Guideline. J Urol 2019; 202:369.</a></li><li><a class="nounderline abstract_t">Herschorn S, Bruschini H, Comiter C, et al. Surgical treatment of stress incontinence in men. Neurourol Urodyn 2010; 29:179.</a></li><li class="breakAll">Abrams P, et al. Incontinence, 5th ed. 5th International Consultation on Incontinence. ICI-ICS. International Continence Society. Bristol, UK 2013.</li><li><a class="nounderline abstract_t">Nitti VW, Mourtzinos A, Brucker BM, SUFU Pad Test Study Group. Correlation of patient perception of pad use with objective degree of incontinence measured by pad test in men with post-prostatectomy incontinence: the SUFU Pad Test Study. J Urol 2014; 192:836.</a></li><li><a class="nounderline abstract_t">Krhut J, Zachoval R, Smith PP, et al. Pad weight testing in the evaluation of urinary incontinence. Neurourol Urodyn 2014; 33:507.</a></li><li><a class="nounderline abstract_t">Gudziak MR, McGuire EJ, Gormley EA. Urodynamic assessment of urethral sphincter function in post-prostatectomy incontinence. J Urol 1996; 156:1131.</a></li><li><a class="nounderline abstract_t">Desautel MG, Kapoor R, Badlani GH. Sphincteric incontinence: the primary cause of post-prostatectomy incontinence in patients with prostate cancer. Neurourol Urodyn 1997; 16:153.</a></li><li><a class="nounderline abstract_t">Huckabay C, Twiss C, Berger A, Nitti VW. A urodynamics protocol to optimally assess men with post-prostatectomy incontinence. Neurourol Urodyn 2005; 24:622.</a></li><li><a class="nounderline abstract_t">Kleinhans B, Gerharz E, Melekos M, et al. Changes of urodynamic findings after radical retropubic prostatectomy. Eur Urol 1999; 35:217.</a></li><li><a class="nounderline abstract_t">Giannantoni A, Mearini E, Di Stasi SM, et al. Assessment of bladder and urethral sphincter function before and after radical retropubic prostatectomy. J Urol 2004; 171:1563.</a></li><li><a class="nounderline abstract_t">Hoffman D, Vijay V, Peng M, et al. Effect of Radiation on Male Stress Urinary Incontinence and the Role of Urodynamic Assessment. Urology 2019; 125:58.</a></li><li><a class="nounderline abstract_t">Ghoniem GM, Bloom DA, McGuire EJ, Stewart KL. Bladder compliance in meningomyelocele children. J Urol 1989; 141:1404.</a></li><li><a class="nounderline abstract_t">O'Sullivan R, Karantanis E, Stevermuer TL, et al. Definition of mild, moderate and severe incontinence on the 24-hour pad test. BJOG 2004; 111:859.</a></li><li><a class="nounderline abstract_t">Rasmussen A, Mouritsen L, Dalgaard A, Frimodt-Møller C. Twenty-four hour pad weighing test: reproducibility and dependency of activity level and fluid intake. Neurourol Urodyn 1994; 13:261.</a></li><li><a class="nounderline abstract_t">Soto González M, Da Cuña Carrera I, Lantarón Caeiro EM, et al. Correlation between the 1-hour and 24-hour pad test in the assessment of male patients with post-prostatectomy urinary incontinence. Prog Urol 2018; 28:536.</a></li><li><a class="nounderline abstract_t">Cornu JN, Sèbe P, Ciofu C, et al. Mid-term evaluation of the transobturator male sling for post-prostatectomy incontinence: focus on prognostic factors. BJU Int 2011; 108:236.</a></li><li><a class="nounderline abstract_t">Kowalik CG, DeLong JM, Mourtzinos AP. The advance transobturator male sling for post-prostatectomy incontinence: subjective and objective outcomes with 3 years follow up. Neurourol Urodyn 2015; 34:251.</a></li><li><a class="nounderline abstract_t">Rehder P, Gozzi C. Transobturator sling suspension for male urinary incontinence including post-radical prostatectomy. Eur Urol 2007; 52:860.</a></li><li><a class="nounderline abstract_t">Rehder P, Freiin von Gleissenthall G, Pichler R, Glodny B. Tratamiento de la incontinencia urinaria post prostatectomía con el cabestrillo retroluminal transobturatriz de reposicionamiento (Advance®): Lecciones aprendidas de la experiencia acumulada. Archivos Españoles de Urología (Ed. impresa) 2009; 62:860.</a></li><li><a class="nounderline abstract_t">Soljanik I, Gozzi C, Becker AJ, et al. Risk factors of treatment failure after retrourethral transobturator male sling. World J Urol 2012; 30:201.</a></li><li><a class="nounderline abstract_t">Barry MJ, Edgman-Levitan S. Shared decision making--pinnacle of patient-centered care. N Engl J Med 2012; 366:780.</a></li><li><a class="nounderline abstract_t">Greenfield S, Kaplan S, Ware JE Jr. Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med 1985; 102:520.</a></li><li><a class="nounderline abstract_t">Greenfield S, Kaplan SH, Ware JE Jr, et al. Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med 1988; 3:448.</a></li><li><a class="nounderline abstract_t">Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care 1989; 27:S110.</a></li><li><a class="nounderline abstract_t">Guadagnoli E, Ward P. Patient participation in decision-making. Soc Sci Med 1998; 47:329.</a></li><li><a class="nounderline abstract_t">Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. J Urol 2019; 202:558.</a></li><li class="breakAll">Yamaguchi Y, Zhao LC, Morey AT. Management of vesicourethral anastomotic stricture. In: Urinary Dysfunction in Prostate Cancer: A Management Guide, Sandhu JS (Ed), Springer International Publishing, Cham 2016. p.101.</li><li><a class="nounderline abstract_t">Afraa TA, Campeau L, Mahfouz W, Corcos J. Urodynamic parameters evolution after artificial urinary sphincter implantation for post-radical prostatectomy incontinence with concomitant bladder dysfunction. Can J Urol 2011; 18:5695.</a></li><li><a class="nounderline abstract_t">Pérez LM, Webster GD. Successful outcome of artificial urinary sphincters in men with post-prostatectomy urinary incontinence despite adverse implantation features. J Urol 1992; 148:1166.</a></li><li><a class="nounderline abstract_t">Trigo-Rocha F, Gomes CM, Pompeo AC, et al. Prospective study evaluating efficacy and safety of Adjustable Continence Therapy (ProACT) for post radical prostatectomy urinary incontinence. Urology 2006; 67:965.</a></li><li><a class="nounderline abstract_t">Poduri A, Wang Y, Gordon D, et al. Novel susceptibility locus at chromosome 6q16.3-22.31 in a family with GEFS+. Neurology 2009; 73:1264.</a></li><li><a class="nounderline abstract_t">Thiel DD, Young PR, Broderick GA, et al. Do clinical or urodynamic parameters predict artificial urinary sphincter outcome in post-radical prostatectomy incontinence? Urology 2007; 69:315.</a></li><li><a class="nounderline abstract_t">Ballert KN, Nitti VW. Association between detrusor overactivity and postoperative outcomes in patients undergoing male bone anchored perineal sling. J Urol 2010; 183:641.</a></li><li><a class="nounderline abstract_t">Hirsh DD, Fainstein V, Musher DM. Do condom catheter collecting systems cause urinary tract infection? JAMA 1979; 242:340.</a></li><li><a class="nounderline abstract_t">Robinson J. Continence: sizing and fitting a penile sheath. Br J Community Nurs 2006; 11:420.</a></li><li><a class="nounderline abstract_t">Macaulay M, Broadbridge J, Gage H, et al. A trial of devices for urinary incontinence after treatment for prostate cancer. BJU Int 2015; 116:432.</a></li><li><a class="nounderline abstract_t">Tsakiris P, de la Rosette JJ, Michel MC, Oelke M. Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence. Eur Urol 2008; 53:53.</a></li><li><a class="nounderline abstract_t">Mottet N, Boyer C, Chartier-Kastler E, et al. Artificial urinary sphincter AMS 800 for urinary incontinence after radical prostatectomy: the French experience. Urol Int 1998; 60 Suppl 2:25.</a></li><li><a class="nounderline abstract_t">Sacomani CAR, Zequi SC, Costa WHD, et al. Long-term results of the implantation of the AMS 800 artificial sphincter for post-prostatectomy incontinence: a single-center experience. Int Braz J Urol 2018; 44:114.</a></li><li><a class="nounderline abstract_t">Walsh IK, Williams SG, Mahendra V, et al. Artificial urinary sphincter implantation in the irradiated patient: safety, efficacy and satisfaction. BJU Int 2002; 89:364.</a></li><li><a class="nounderline abstract_t">Gomha MA, Boone TB. Artificial urinary sphincter for post-prostatectomy incontinence in men who had prior radiotherapy: a risk and outcome analysis. J Urol 2002; 167:591.</a></li><li><a class="nounderline abstract_t">Litwiller SE, Kim KB, Fone PD, et al. Post-prostatectomy incontinence and the artificial urinary sphincter: a long-term study of patient satisfaction and criteria for success. J Urol 1996; 156:1975.</a></li><li><a class="nounderline abstract_t">Trigo Rocha F, Gomes CM, Mitre AI, et al. A prospective study evaluating the efficacy of the artificial sphincter AMS 800 for the treatment of postradical prostatectomy urinary incontinence and the correlation between preoperative urodynamic and surgical outcomes. Urology 2008; 71:85.</a></li><li><a class="nounderline abstract_t">Guillaumier S, Solomon E, Jenks J, et al. Radiotherapy is associated with reduced continence outcomes following implantation of the artificial urinary sphincter in men with post-radical prostatectomy incontinence. Urol Ann 2017; 9:253.</a></li><li><a class="nounderline abstract_t">Kuznetsov DD, Kim HL, Patel RV, et al. Comparison of artificial urinary sphincter and collagen for the treatment of postprostatectomy incontinence. Urology 2000; 56:600.</a></li><li><a class="nounderline abstract_t">Gousse AE, Madjar S, Lambert MM, Fishman IJ. Artificial urinary sphincter for post-radical prostatectomy urinary incontinence: long-term subjective results. J Urol 2001; 166:1755.</a></li><li><a class="nounderline abstract_t">Santos AC Junior, Rodrigues LO, Azevedo DC, et al. Artificial urinary sphincter for urinary incontinence after radical prostatectomy: a historical cohort from 2004 to 2015. Int Braz J Urol 2017; 43:150.</a></li><li><a class="nounderline abstract_t">Lai HH, Hsu EI, Teh BS, et al. 13 years of experience with artificial urinary sphincter implantation at Baylor College of Medicine. J Urol 2007; 177:1021.</a></li><li><a class="nounderline abstract_t">Scott FB, Bradley WE, Timm GW. Treatment of urinary incontinence by an implantable prosthetic urinary sphincter. 1974. J Urol 2002; 167:1125.</a></li><li><a class="nounderline abstract_t">Henry GD, Graham SM, Cornell RJ, et al. A multicenter study on the perineal versus penoscrotal approach for implantation of an artificial urinary sphincter: cuff size and control of male stress urinary incontinence. J Urol 2009; 182:2404.</a></li><li><a class="nounderline abstract_t">Kretschmer A, Hüsch T, Thomsen F, et al. Complications and Short-Term Explantation Rate Following Artificial Urinary Sphincter Implantation: Results from a Large Middle European Multi-Institutional Case Series. Urol Int 2016; 97:205.</a></li><li><a class="nounderline abstract_t">Raj GV, Peterson AC, Toh KL, Webster GD. Outcomes following revisions and secondary implantation of the artificial urinary sphincter. J Urol 2005; 173:1242.</a></li><li><a class="nounderline abstract_t">Kowalczyk JJ, Nelson R, Mulcahy JJ. Successful reinsertion of the artificial urinary sphincter after removal for erosion or infection. Urology 1996; 48:906.</a></li><li><a class="nounderline abstract_t">Motley RC, Barrett DM. Artificial urinary sphincter cuff erosion. Experience with reimplantation in 38 patients. Urology 1990; 35:215.</a></li><li><a class="nounderline abstract_t">Rozanski AT, Tausch TJ, Ramirez D, et al. Immediate urethral repair during explantation prevents stricture formation after artificial urinary sphincter cuff erosion. J Urol 2014; 192:442.</a></li><li><a class="nounderline abstract_t">Bryan DE, Mulcahy JJ, Simmons GR. Salvage procedure for infected noneroded artificial urinary sphincters. J Urol 2002; 168:2464.</a></li><li><a class="nounderline abstract_t">Linder BJ, de Cogain M, Elliott DS. Long-term device outcomes of artificial urinary sphincter reimplantation following prior explantation for erosion or infection. J Urol 2014; 191:734.</a></li><li><a class="nounderline abstract_t">Lai HH, Boone TB. Complex artificial urinary sphincter revision and reimplantation cases--how do they fare compared to virgin cases? J Urol 2012; 187:951.</a></li><li><a class="nounderline abstract_t">Ahyai SA, Ludwig TA, Dahlem R, et al. Outcomes of single- vs double-cuff artificial urinary sphincter insertion in low- and high-risk profile male patients with severe stress urinary incontinence. BJU Int 2016; 118:625.</a></li><li><a class="nounderline abstract_t">O'Connor RC, Lyon MB, Guralnick ML, Bales GT. Long-term follow-up of single versus double cuff artificial urinary sphincter insertion for the treatment of severe postprostatectomy stress urinary incontinence. Urology 2008; 71:90.</a></li><li><a class="nounderline abstract_t">Viers BR, Linder BJ, Rivera ME, et al. Long-Term Quality of Life and Functional Outcomes among Primary and Secondary Artificial Urinary Sphincter Implantations in Men with Stress Urinary Incontinence. J Urol 2016; 196:838.</a></li><li><a class="nounderline abstract_t">Cornu JN, Sèbe P, Ciofu C, et al. The AdVance transobturator male sling for postprostatectomy incontinence: clinical results of a prospective evaluation after a minimum follow-up of 6 months. Eur Urol 2009; 56:923.</a></li><li><a class="nounderline abstract_t">Bauer RM, Soljanik I, Füllhase C, et al. Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy. BJU Int 2011; 108:94.</a></li><li><a class="nounderline abstract_t">Comiter C. Surgery for postprostatectomy incontinence: which procedure for which patient? Nat Rev Urol 2015; 12:91.</a></li><li class="breakAll">Suarez OA, Chung AS, McCammon K. The AdVance transobturator male sling. In: Post-Prostatectomy Incontinence: Evaluation and Management, Singla AK, Comiter C (Eds), Springer International Publishing, 2017.</li><li><a class="nounderline abstract_t">Comiter CV, Nitti V, Elliot C, Rhee E. A new quadratic sling for male stress incontinence: retrograde leak point pressure as a measure of urethral resistance. J Urol 2012; 187:563.</a></li><li class="breakAll">Comiter CV. The Virtue quadratic sling for post-prostatectomy incontinence. In: Post-Prostatectomy Incontinence: Evaluation and Management, Singla A, Comiter C (Eds), Springer International Publishing, 2017. p.77.</li><li><a class="nounderline abstract_t">Comiter CV, Rhee EY, Tu LM, et al. The virtue sling--a new quadratic sling for postprostatectomy incontinence--results of a multinational clinical trial. Urology 2014; 84:433.</a></li><li><a class="nounderline abstract_t">Sahai A, Abrams P, Dmochowski R, Anding R. The role of male slings in post prostatectomy incontinence: ICI-RS 2015. Neurourol Urodyn 2017; 36:927.</a></li><li><a class="nounderline abstract_t">Meisterhofer K, Herzog S, Strini KA, et al. Male Slings for Postprostatectomy Incontinence: A Systematic Review and Meta-analysis. Eur Urol Focus 2020; 6:575.</a></li><li><a class="nounderline abstract_t">Silva LAD, Simonetti R, Silva EMKD. Adjustable sling for the treatment of post-prostatectomy urinary incontinence: systematic review and meta-analysis. Einstein (Sao Paulo) 2019; 17:eRW4508.</a></li><li><a class="nounderline abstract_t">Trost L, Elliott DS. Male stress urinary incontinence: a review of surgical treatment options and outcomes. Adv Urol 2012; 2012:287489.</a></li><li><a class="nounderline abstract_t">Soljanik I, Becker AJ, Stief CG, et al. Urodynamic parameters after retrourethral transobturator male sling and their influence on outcome. Urology 2011; 78:708.</a></li><li><a class="nounderline abstract_t">Bauer RM, Mayer ME, May F, et al. Complications of the AdVance transobturator male sling in the treatment of male stress urinary incontinence. Urology 2010; 75:1494.</a></li><li><a class="nounderline abstract_t">Rehder P, Mitterberger MJ, Pichler R, et al. The 1 year outcome of the transobturator retroluminal repositioning sling in the treatment of male stress urinary incontinence. BJU Int 2010; 106:1668.</a></li><li><a class="nounderline abstract_t">Rouprêt M, Misraï V, Gosseine PN, et al. Management of stress urinary incontinence following prostate surgery with minimally invasive adjustable continence balloon implants: functional results from a single center prospective study. J Urol 2011; 186:198.</a></li><li><a class="nounderline abstract_t">Finazzi Agrò E, Gregori A, Bianchi D, et al. Efficacy and safety of adjustable balloons (Proact™) to treat male stress urinary incontinence after prostate surgery: Medium and long-term follow-up data of a national multicentric retrospective study. Neurourol Urodyn 2019; 38:1979.</a></li><li class="breakAll">Hubner WA. ProACT for treatment of male SUI. In: Post-Prostatectomy Incontinence: Evaluation and Management, Singla A, Comiter C (Eds), Springer International Publishing, 2017. p.117.</li><li><a class="nounderline abstract_t">Hübner WA, Schlarp OM. Treatment of incontinence after prostatectomy using a new minimally invasive device: adjustable continence therapy. BJU Int 2005; 96:587.</a></li><li><a class="nounderline abstract_t">Larson T, Jhaveri H, Yeung LL. Adjustable continence therapy (ProACT) for the treatment of male stress urinary incontinence: A systematic review and meta-analysis. Neurourol Urodyn 2019; 38:2051.</a></li><li><a class="nounderline abstract_t">Angulo JC, Schönburg S, Giammò A, et al. Systematic review and meta-analysis comparing Adjustable Transobturator Male System (ATOMS) and Adjustable Continence Therapy (ProACT) for male stress incontinence. PLoS One 2019; 14:e0225762.</a></li><li><a class="nounderline abstract_t">Abrams P, Constable LD, Cooper D, et al. Outcomes of a Noninferiority Randomised Controlled Trial of Surgery for Men with Urodynamic Stress Incontinence After Prostate Surgery (MASTER). Eur Urol 2021; 79:812.</a></li><li><a class="nounderline abstract_t">Rehder P, Berger T, Kiss G, et al. Advance male sling: Anatomic evidence of retrourethral position after tensioning without direct urethral compression. European Urology Supplements 2008; 7:87.</a></li><li><a class="nounderline abstract_t">Bauer RM, Mayer ME, Gratzke C, et al. Prospective evaluation of the functional sling suspension for male postprostatectomy stress urinary incontinence: results after 1 year. Eur Urol 2009; 56:928.</a></li><li><a class="nounderline abstract_t">Bauer RM, Gozzi C, Roosen A, et al. Impact of the 'repositioning test' on postoperative outcome of retroluminar transobturator male sling implantation. Urol Int 2013; 90:334.</a></li><li><a class="nounderline abstract_t">Collado Serra A, Resel Folkersma L, Domínguez-Escrig JL, et al. AdVance/AdVance XP transobturator male slings: preoperative degree of incontinence as predictor of surgical outcome. Urology 2013; 81:1034.</a></li><li><a class="nounderline abstract_t">Ferro M, Bottero D, D'Elia C, et al. Virtue male sling for post-prostatectomy stress incontinence: a prospective evaluation and mid-term outcomes. BJU Int 2017; 119:482.</a></li><li><a class="nounderline abstract_t">Torrey R, Rajeshuni N, Ruel N, et al. Radiation history affects continence outcomes after advance transobturator sling placement in patients with post-prostatectomy incontinence. Urology 2013; 82:713.</a></li><li><a class="nounderline abstract_t">Friedl A, Mühlstädt S, Rom M, et al. Risk Factors for Treatment Failure With the Adjustable Transobturator Male System Incontinence Device: Who Will Succeed, Who Will Fail? Results of a Multicenter Study. Urology 2016; 90:189.</a></li><li><a class="nounderline abstract_t">Hüsch T, Kretschmer A, Thomsen F, et al. Risk Factors for Failure of Male Slings and Artificial Urinary Sphincters: Results from a Large Middle European Cohort Study. Urol Int 2017; 99:14.</a></li><li><a class="nounderline abstract_t">Gratzke C, Bachmann A, Descazeaud A, et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Eur Urol 2015; 67:1099.</a></li><li><a class="nounderline abstract_t">Polland A, Vertosick EA, Sjoberg DD, et al. Preoperative symptoms predict continence after post-radiation transurethral resection of prostate. Can J Urol 2017; 24:8903.</a></li><li><a class="nounderline abstract_t">Gundian JC, Barrett DM, Parulkar BG. Mayo Clinic experience with the AS800 artificial urinary sphincter for urinary incontinence after transurethral resection of prostate or open prostatectomy. Urology 1993; 41:318.</a></li><li><a class="nounderline abstract_t">Hogewoning CRC, Meij LAM, Pelger RCM, et al. Sling Surgery for the Treatment of Urinary Incontinence After Transurethral Resection of the Prostate: New Data on the Virtue Male Sling and an Evaluation of Literature. Urology 2017; 100:187.</a></li><li><a class="nounderline abstract_t">Clavell-Hernández J, Martin C, Wang R. Orgasmic Dysfunction Following Radical Prostatectomy: Review of Current Literature. Sex Med Rev 2018; 6:124.</a></li><li><a class="nounderline abstract_t">Mendez MH, Sexton SJ, Lentz AC. Contemporary Review of Male and Female Climacturia and Urinary Leakage During Sexual Activities. Sex Med Rev 2018; 6:16.</a></li><li><a class="nounderline abstract_t">Choi JM, Nelson CJ, Stasi J, Mulhall JP. Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors. J Urol 2007; 177:2223.</a></li><li><a class="nounderline abstract_t">Mehta A, Deveci S, Mulhall JP. Efficacy of a penile variable tension loop for improving climacturia after radical prostatectomy. BJU Int 2013; 111:500.</a></li><li><a class="nounderline abstract_t">Jain R, Mitchell S, Laze J, Lepor H. The effect of surgical intervention for stress urinary incontinence (UI) on post-prostatectomy UI during sexual activity. BJU Int 2012; 109:1208.</a></li><li><a class="nounderline abstract_t">Christine B, Bella A. P-06-011 Climacturia: An under-addressed sequela of radical prostatectomy, but treatment is only a sling away. The Journal of Sexual Medicine 2016; 13:S231.</a></li><li><a class="nounderline abstract_t">Boysen WR, Cohen AJ, Kuchta K, et al. Combined Placement of Artificial Urinary Sphincter and Inflatable Penile Prosthesis Does Not Increase Risk of Perioperative Complications or Impact Long-term Device Survival. Urology 2019; 124:264.</a></li><li><a class="nounderline abstract_t">Segal RL, Cabrini MR, Harris ED, et al. Combined inflatable penile prosthesis-artificial urinary sphincter implantation: no increased risk of adverse events compared to single or staged device implantation. J Urol 2013; 190:2183.</a></li><li><a class="nounderline abstract_t">King T, Almallah YZ. Post-radical-prostatectomy urinary incontinence: the management of concomitant bladder neck contracture. Adv Urol 2012; 2012:295798.</a></li><li><a class="nounderline abstract_t">Eriksson K, Metsäranta P, Huhtala H, et al. Treatment delay and the risk of prolonged status epilepticus. Neurology 2005; 65:1316.</a></li><li><a class="nounderline abstract_t">Anger JT, Raj GV, Delvecchio FC, Webster GD. Anastomotic contracture and incontinence after radical prostatectomy: a graded approach to management. J Urol 2005; 173:1143.</a></li><li><a class="nounderline abstract_t">Maillet F, Buzelin JM, Bouchot O, Karam G. Management of artificial urinary sphincter dysfunction. Eur Urol 2004; 46:241.</a></li><li><a class="nounderline abstract_t">Peterson AC, Webster GD. Artificial urinary sphincter: lessons learned. Urol Clin North Am 2011; 38:83.</a></li><li class="breakAll">Linder BJ, Elliott DS. Use of the artificial urinary sphincter in the management of post-prostatectomy incontinence. In: Post-Prostatectomy Incontinence: Evaluation and Management, Singla A, Comiter C (Eds), Springer International Publishing, 2017. p.125.</li><li><a class="nounderline abstract_t">Soljanik I, Becker AJ, Stief CG, et al. Repeat retrourethral transobturator sling in the management of recurrent postprostatectomy stress urinary incontinence after failed first male sling. Eur Urol 2010; 58:767.</a></li><li><a class="nounderline abstract_t">Martinez EJ, Zuckerman JM, Henderson K, et al. Evaluation of salvage male transobturator sling placement following recurrent stress urinary incontinence after failed transobturator sling. Urology 2015; 85:478.</a></li><li><a class="nounderline abstract_t">Angulo JC, Esquinas C, Arance I, et al. Adjustable Transobturator Male System after Failed Surgical Devices for Male Stress Urinary Incontinence: A Feasibility Study. Urol Int 2018; 101:106.</a></li><li><a class="nounderline abstract_t">Ajay D, Zhang H, Gupta S, et al. The Artificial Urinary Sphincter is Superior to a Secondary Transobturator Male Sling in Cases of a Primary Sling Failure. J Urol 2015; 194:1038.</a></li><li><a class="nounderline abstract_t">Fisher MB, Aggarwal N, Vuruskan H, Singla AK. Efficacy of artificial urinary sphincter implantation after failed bone-anchored male sling for postprostatectomy incontinence. Urology 2007; 70:942.</a></li><li><a class="nounderline abstract_t">Lentz AC, Peterson AC, Webster GD. Outcomes following artificial sphincter implantation after prior unsuccessful male sling. J Urol 2012; 187:2149.</a></li><li><a class="nounderline abstract_t">Kim PH, Pinheiro LC, Atoria CL, et al. Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis. J Urol 2013; 189:602.</a></li><li class="breakAll">Staskin DR, Comiter CV. Surgical treatment of male sphincteric urinary incontinence: The male perineal sling and artificial urinary sphincter. In: Campbell-Walsh Urology, Wein AJ (Ed), W.B. Saunders, Philadelphia 2007. p.2391.</li><li><a class="nounderline abstract_t">Comiter CV, Dobberfuhl AD. The artificial urinary sphincter and male sling for postprostatectomy incontinence: Which patient should get which procedure? Investig Clin Urol 2016; 57:3.</a></li></ol></div><div id="topicVersionRevision">Topic 15176 Version 5.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15837992" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22704098" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16686718" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22749852" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8976260" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Urodynamic evaluation of changes in urinary control after radical retropubic prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9037284" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Prospective assessment of incontinence after radical retropubic prostatectomy: objective and subjective analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21538499" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Predictor of de novo urinary incontinence following holmium laser enucleation of the prostate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29538164" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Evidence-based outcomes of holmium laser enucleation of the prostate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27209330" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Prospective study comparing laparoscopic and open adenomectomy: Surgical and functional results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25261861" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16469429" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26162846" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Predictors of de novo urge urinary incontinence after photoselective vaporization of the prostate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23832420" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Development and validation of nomograms to predict the recovery of urinary continence after radical prostatectomy: comparisons between immediate, early, and late continence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25682782" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Preoperative predictive model of recovery of urinary continence after radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10953138" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prospective assessment of patient reported urinary continence after radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25457018" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Degree of preservation of the neurovascular bundles during radical prostatectomy and urinary continence 1 year after surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10647798" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33967010" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10489956" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Urinary incontinence in the elderly and age-dependent apoptosis of rhabdosphincter cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27394644" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Preoperative Membranous Urethral Length Measurement and Continence Recovery Following Radical Prostatectomy: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34101272" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Evaluation of image-based prognostic parameters of post-prostatectomy urinary incontinence: A literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23669568" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15711274" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9531361" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24314031" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Complications and outcomes of salvage robot-assisted radical prostatectomy: a single-institution experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15538239" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26352154" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Use of preoperative factors including urodynamic evaluations and nerve-sparing status for predicting urinary continence recovery after robot-assisted radical prostatectomy: Nerve-sparing technique contributes to the reduction of postprostatectomy incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24332640" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The effect of BMI on clinicopathologic and functional outcomes after open radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10799178" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The pathophysiology of post-radical prostatectomy incontinence: a clinical and video urodynamic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29635709" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : De novo overactive bladder after robot-assisted laparoscopic radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27181241" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Overactive Bladder and Storage Lower Urinary Tract Symptoms Following Radical Prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16040102" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Comprehensive urodynamics evaluation of 146 men with incontinence after radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22990061" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Maximum isometric detrusor pressure to measure bladder strength in men with postprostatectomy incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11306394" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22196405" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Risk factors and quality of life for post-prostatectomy vesicourethral anastomotic stenoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19076148" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : An analysis of the causes of bladder neck contracture after open and robot-assisted laparoscopic radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20438567" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19530903" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Bipolar transurethral resection in saline (TURis): outcome and complication rates after the first 1000 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15780363" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Comprehensive study of bladder neck contracture after transurethral resection of prostate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7776413" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Incontinence after radical prostatectomy: detrusor or sphincter causes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7776413" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Incontinence after radical prostatectomy: detrusor or sphincter causes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17487874" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Contribution of early intensive prolonged pelvic floor exercises on urinary continence recovery after bladder neck-sparing radical prostatectomy: results of a prospective controlled randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23432098" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Preoperative pelvic floor physiotherapy improves continence after radical retropubic prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20227168" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Preoperative pelvic floor muscle exercise for early continence after radical prostatectomy: a randomised controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26538105" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Pelvic floor muscle training for erectile dysfunction and climacturia 1 year after nerve sparing radical prostatectomy: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11018619" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Effect of preoperative biofeedback/pelvic floor training on continence in men undergoing radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16406909" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Preoperative biofeedback assisted behavioral training to decrease post-prostatectomy incontinence: a randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12796664" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The role of pelvic floor exercises on post-prostatectomy incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22332815" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18448233" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Does physiotherapist-guided pelvic floor muscle training reduce urinary incontinence after radical prostatectomy? A randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25427689" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Improvement of continence rate with pelvic floor muscle training post-prostatectomy: a meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31882228" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Reconsideration of pelvic floor muscle training to prevent and treat incontinence after radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19233390" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Early recovery of urinary continence after radical prostatectomy using early pelvic floor electrical stimulation and biofeedback associated treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20332469" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Pelvic floor rehabilitation for continence recovery after radical prostatectomy: role of a personal training re-educational program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10675166" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Effect of pelvic-floor re-education on duration and degree of incontinence after radical prostatectomy: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25602133" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Conservative management for postprostatectomy urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18384853" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Return to continence after radical retropubic prostatectomy: a randomized trial of verbal and written instructions versus therapist-directed pelvic floor muscle therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11966630" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Biofeedback vs verbal feedback as learning tools for pelvic muscle exercises in the early management of urinary incontinence after radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20643454" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Long-term effect of early postoperative pelvic floor biofeedback on continence in men undergoing radical prostatectomy: a prospective, randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21224456" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Behavioral therapy with or without biofeedback and pelvic floor electrical stimulation for persistent postprostatectomy incontinence: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34550846" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Supervised pelvic floor muscle exercise is more effective than unsupervised pelvic floor muscle exercise at improving urinary incontinence in prostate cancer patients following radical prostatectomy - a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12853806" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Pelvic floor exercises, electrical stimulation and biofeedback after radical prostatectomy: results of a prospective randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9751344" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The etiology of post-radical prostatectomy incontinence and correlation of symptoms with urodynamic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31059663" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Incontinence after Prostate Treatment: AUA/SUFU Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20025026" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Surgical treatment of stress incontinence in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20025026" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Surgical treatment of stress incontinence in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24650425" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Correlation of patient perception of pad use with objective degree of incontinence measured by pad test in men with post-prostatectomy incontinence: the SUFU Pad Test Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23797972" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Pad weight testing in the evaluation of urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8709325" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Urodynamic assessment of urethral sphincter function in post-prostatectomy incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9136137" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Sphincteric incontinence: the primary cause of post-prostatectomy incontinence in patients with prostate cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16208638" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A urodynamics protocol to optimally assess men with post-prostatectomy incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10072623" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Changes of urodynamic findings after radical retropubic prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15017221" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Assessment of bladder and urethral sphincter function before and after radical retropubic prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30508511" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Effect of Radiation on Male Stress Urinary Incontinence and the Role of Urodynamic Assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2724439" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Bladder compliance in meningomyelocele children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15270937" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Definition of mild, moderate and severe incontinence on the 24-hour pad test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7920683" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Twenty-four hour pad weighing test: reproducibility and dependency of activity level and fluid intake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30037454" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Correlation between the 1-hour and 24-hour pad test in the assessment of male patients with post-prostatectomy urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20955265" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Mid-term evaluation of the transobturator male sling for post-prostatectomy incontinence: focus on prognostic factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24318744" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : The advance transobturator male sling for post-prostatectomy incontinence: subjective and objective outcomes with 3 years follow up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17316969" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Transobturator sling suspension for male urinary incontinence including post-radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Tratamiento de la incontinencia urinaria post prostatectomía con el cabestrillo retroluminal transobturatriz de reposicionamiento (Advance®): Lecciones aprendidas de la experiencia acumulada</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21416252" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Risk factors of treatment failure after retrourethral transobturator male sling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22375967" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Shared decision making--pinnacle of patient-centered care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3977198" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Expanding patient involvement in care. Effects on patient outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3049968" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2646486" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Assessing the effects of physician-patient interactions on the outcomes of chronic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9681902" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Patient participation in decision-making.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31039103" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31039103" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21703042" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Urodynamic parameters evolution after artificial urinary sphincter implantation for post-radical prostatectomy incontinence with concomitant bladder dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1404630" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Successful outcome of artificial urinary sphincters in men with post-prostatectomy urinary incontinence despite adverse implantation features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16698356" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Prospective study evaluating efficacy and safety of Adjustable Continence Therapy (ProACT) for post radical prostatectomy urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19841378" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Novel susceptibility locus at chromosome 6q16.3-22.31 in a family with GEFS+.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17320671" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Do clinical or urodynamic parameters predict artificial urinary sphincter outcome in post-radical prostatectomy incontinence?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20018325" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Association between detrusor overactivity and postoperative outcomes in patients undergoing male bone anchored perineal sling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/448937" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Do condom catheter collecting systems cause urinary tract infection?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17167355" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Continence: sizing and fitting a penile sheath.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25496354" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : A trial of devices for urinary incontinence after treatment for prostate cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17920183" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9607555" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Artificial urinary sphincter AMS 800 for urinary incontinence after radical prostatectomy: the French experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29211407" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Long-term results of the implantation of the AMS 800 artificial sphincter for post-prostatectomy incontinence: a single-center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11872025" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Artificial urinary sphincter implantation in the irradiated patient: safety, efficacy and satisfaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11792924" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Artificial urinary sphincter for post-prostatectomy incontinence in men who had prior radiotherapy: a risk and outcome analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8911369" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Post-prostatectomy incontinence and the artificial urinary sphincter: a long-term study of patient satisfaction and criteria for success.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18242371" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : A prospective study evaluating the efficacy of the artificial sphincter AMS 800 for the treatment of postradical prostatectomy urinary incontinence and the correlation between preoperative urodynamic and surgical outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28794592" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Radiotherapy is associated with reduced continence outcomes following implantation of the artificial urinary sphincter in men with post-radical prostatectomy incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11018614" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Comparison of artificial urinary sphincter and collagen for the treatment of postprostatectomy incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11586217" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Artificial urinary sphincter for post-radical prostatectomy urinary incontinence: long-term subjective results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28124538" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Artificial urinary sphincter for urinary incontinence after radical prostatectomy: a historical cohort from 2004 to 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17296403" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : 13 years of experience with artificial urinary sphincter implantation at Baylor College of Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11905886" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Treatment of urinary incontinence by an implantable prosthetic urinary sphincter. 1974.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19762042" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : A multicenter study on the perineal versus penoscrotal approach for implantation of an artificial urinary sphincter: cuff size and control of male stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27310718" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Complications and Short-Term Explantation Rate Following Artificial Urinary Sphincter Implantation: Results from a Large Middle European Multi-Institutional Case Series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15758761" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Outcomes following revisions and secondary implantation of the artificial urinary sphincter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8973675" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Successful reinsertion of the artificial urinary sphincter after removal for erosion or infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2316084" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Artificial urinary sphincter cuff erosion. Experience with reimplantation in 38 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24512955" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Immediate urethral repair during explantation prevents stricture formation after artificial urinary sphincter cuff erosion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12441941" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Salvage procedure for infected noneroded artificial urinary sphincters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24018241" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Long-term device outcomes of artificial urinary sphincter reimplantation following prior explantation for erosion or infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22264456" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Complex artificial urinary sphincter revision and reimplantation cases--how do they fare compared to virgin cases?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26917355" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Outcomes of single- vs double-cuff artificial urinary sphincter insertion in low- and high-risk profile male patients with severe stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18242372" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Long-term follow-up of single versus double cuff artificial urinary sphincter insertion for the treatment of severe postprostatectomy stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26997310" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Long-Term Quality of Life and Functional Outcomes among Primary and Secondary Artificial Urinary Sphincter Implantations in Men with Stress Urinary Incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19748174" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : The AdVance transobturator male sling for postprostatectomy incontinence: clinical results of a prospective evaluation after a minimum follow-up of 6 months.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20883489" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25558839" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Surgery for postprostatectomy incontinence: which procedure for which patient?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25558839" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Surgery for postprostatectomy incontinence: which procedure for which patient?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22177174" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : A new quadratic sling for male stress incontinence: retrograde leak point pressure as a measure of urethral resistance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22177174" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : A new quadratic sling for male stress incontinence: retrograde leak point pressure as a measure of urethral resistance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24972946" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : The virtue sling--a new quadratic sling for postprostatectomy incontinence--results of a multinational clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28444702" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : The role of male slings in post prostatectomy incontinence: ICI-RS 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30718160" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Male Slings for Postprostatectomy Incontinence: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31553360" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Adjustable sling for the treatment of post-prostatectomy urinary incontinence: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22649446" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Male stress urinary incontinence: a review of surgical treatment options and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21777955" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Urodynamic parameters after retrourethral transobturator male sling and their influence on outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20156654" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Complications of the AdVance transobturator male sling in the treatment of male stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20518761" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : The 1 year outcome of the transobturator retroluminal repositioning sling in the treatment of male stress urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21575974" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Management of stress urinary incontinence following prostate surgery with minimally invasive adjustable continence balloon implants: functional results from a single center prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31302928" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Efficacy and safety of adjustable balloons (Proact™) to treat male stress urinary incontinence after prostate surgery: Medium and long-term follow-up data of a national multicentric retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31302928" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Efficacy and safety of adjustable balloons (Proact™) to treat male stress urinary incontinence after prostate surgery: Medium and long-term follow-up data of a national multicentric retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16104915" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Treatment of incontinence after prostatectomy using a new minimally invasive device: adjustable continence therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31429982" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Adjustable continence therapy (ProACT) for the treatment of male stress urinary incontinence: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31790490" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Systematic review and meta-analysis comparing Adjustable Transobturator Male System (ATOMS) and Adjustable Continence Therapy (ProACT) for male stress incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33551297" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Outcomes of a Noninferiority Randomised Controlled Trial of Surgery for Men with Urodynamic Stress Incontinence After Prostate Surgery (MASTER).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Advance male sling: Anatomic evidence of retrourethral position after tensioning without direct urethral compression</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19660850" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Prospective evaluation of the functional sling suspension for male postprostatectomy stress urinary incontinence: results after 1 year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23485964" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Impact of the 'repositioning test' on postoperative outcome of retroluminar transobturator male sling implantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23465151" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : AdVance/AdVance XP transobturator male slings: preoperative degree of incontinence as predictor of surgical outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27696622" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Virtue male sling for post-prostatectomy stress incontinence: a prospective evaluation and mid-term outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23831073" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Radiation history affects continence outcomes after advance transobturator sling placement in patients with post-prostatectomy incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26773347" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Risk Factors for Treatment Failure With the Adjustable Transobturator Male System Incontinence Device: Who Will Succeed, Who Will Fail? Results of a Multicenter Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27598774" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Risk Factors for Failure of Male Slings and Artificial Urinary Sphincters: Results from a Large Middle European Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25613154" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28832309" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Preoperative symptoms predict continence after post-radiation transurethral resection of prostate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8470315" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Mayo Clinic experience with the AS800 artificial urinary sphincter for urinary incontinence after transurethral resection of prostate or open prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27773648" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Sling Surgery for the Treatment of Urinary Incontinence After Transurethral Resection of the Prostate: New Data on the Virtue Male Sling and an Evaluation of Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29108976" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Orgasmic Dysfunction Following Radical Prostatectomy: Review of Current Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28941806" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Contemporary Review of Male and Female Climacturia and Urinary Leakage During Sexual Activities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17509325" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22672308" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Efficacy of a penile variable tension loop for improving climacturia after radical prostatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21895932" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : The effect of surgical intervention for stress urinary incontinence (UI) on post-prostatectomy UI during sexual activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : P-06-011 Climacturia: An under-addressed sequela of radical prostatectomy, but treatment is only a sling away</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30786981" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Combined Placement of Artificial Urinary Sphincter and Inflatable Penile Prosthesis Does Not Increase Risk of Perioperative Complications or Impact Long-term Device Survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23831315" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Combined inflatable penile prosthesis-artificial urinary sphincter implantation: no increased risk of adverse events compared to single or staged device implantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22611382" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : Post-radical-prostatectomy urinary incontinence: the management of concomitant bladder neck contracture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16247069" id="rid166" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>167 : Treatment delay and the risk of prolonged status epilepticus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15758723" id="rid167" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>168 : Anastomotic contracture and incontinence after radical prostatectomy: a graded approach to management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15245820" id="rid168" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>169 : Management of artificial urinary sphincter dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21353083" id="rid169" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>170 : Artificial urinary sphincter: lessons learned.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21353083" id="rid170" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>171 : Artificial urinary sphincter: lessons learned.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20843598" id="rid171" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>172 : Repeat retrourethral transobturator sling in the management of recurrent postprostatectomy stress urinary incontinence after failed first male sling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25559726" id="rid172" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>173 : Evaluation of salvage male transobturator sling placement following recurrent stress urinary incontinence after failed transobturator sling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29953998" id="rid173" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>174 : Adjustable Transobturator Male System after Failed Surgical Devices for Male Stress Urinary Incontinence: A Feasibility Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25963183" id="rid174" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>175 : The Artificial Urinary Sphincter is Superior to a Secondary Transobturator Male Sling in Cases of a Primary Sling Failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18068452" id="rid175" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>176 : Efficacy of artificial urinary sphincter implantation after failed bone-anchored male sling for postprostatectomy incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22503016" id="rid176" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>177 : Outcomes following artificial sphincter implantation after prior unsuccessful male sling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23017528" id="rid177" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>178 : Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23017528" id="rid178" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>179 : Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26966721" id="rid179" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>180 : The artificial urinary sphincter and male sling for postprostatectomy incontinence: Which patient should get which procedure?</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
